Is Online Motor Control Really Impaired In Parkinson\u27s Disease? by Merritt, Kate E
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
8-18-2016 12:00 AM 
Is Online Motor Control Really Impaired In Parkinson's Disease? 
Kate E. Merritt 
The University of Western Ontario 
Supervisor 
Dr. Penny MacDonald 
The University of Western Ontario Joint Supervisor 
Dr. Melvyn Goodale 
The University of Western Ontario 
Graduate Program in Neuroscience 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Kate E. Merritt 2016 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Cognitive Neuroscience Commons, Nervous System Diseases Commons, and the 
Neurosciences Commons 
Recommended Citation 
Merritt, Kate E., "Is Online Motor Control Really Impaired In Parkinson's Disease?" (2016). Electronic 
Thesis and Dissertation Repository. 4078. 
https://ir.lib.uwo.ca/etd/4078 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
	  	  i	  
Abstract 
Patients with Parkinson’s disease (PD) are thought to be selectively impaired in 
consciously-mediated online automatic motor control, whereas the ability to perform 
subconscious online adjustments remains intact. This present study evaluates the hypothesis 
that the previously alleged deficits in online motor control in PD are not due to the 
consciousness of the correction, but rather are attributable to aspects of the prior 
experimental designs disproportionately penalizing patients for PD-related bradykinesia. 
Here, we implemented a modified traditional double-step paradigm to investigate 
consciously-mediated online motor control in PD, in a manner that would be unconfounded 
by disease-related bradykinesia. Further, we investigated the effects of dopamine-
replacement therapy on performance. We found that PD patients (n=12) and healthy-matched 
controls (n=12) were equal in performing automatic online corrections whether or not these 
corrections were consciously perceived, and their performance was unaffected by 
dopaminergic therapy. These findings inform our understanding of automatic motor control 
in PD. 
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Chapter 1: Introduction 
1.1 Summary of Online Motor Control  
Fast and precise modifications to motor plans can be implemented while actions are 
occurring (i.e. online).  This flexibility with respect to predefined motor plans is incredibly 
adaptive. Continuous real-time supervision of an ongoing movement is achieved through 
feedback loops comparing the limb and goal positions. Through this mechanism, motor error 
signals can be generated and adjustments in limb position can be promptly induced in 
response to changing task demands, such as when the target location changes, or simply 
when the initial motor plan is imperfect (Bard et al., 1999; Desmurget et al., 1999; Gréa et 
al., 2000).  
Evidence validating the rapid online control of action has primarily stemmed from the 
use of a behavioral task known as the ‘double-step’ paradigm. In this experimental design, 
participants are instructed to point to a peripheral visual target, which depending on the trial, 
will either remain stationary or will unexpectedly change locations at hand movement onset.  
These target perturbations rapidly induce changes in limb trajectory away from its original 
path and toward the new goal location. Such unexpected target displacements provide a 
valuable opportunity to investigate how planned actions are adapted in real-time following 
their initiation.  
1.1.2 Psychophysics of Online Corrections  
Accurate and rapid online motor control relies heavily on the multisensory fusion of 
visual, proprioceptive, and vestibular modalities, as well as fast internal feed-forward and 
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feedback loops (Prablanc et al., 1979; Todorov & Jordan, 2002). To fully understand the 
mechanisms involved in online corrections, it is first important to break down the 
psychophysics of pointing movements directed at stationary targets.  
Neurophysiological studies have identified a latency of 60-100 ms between the overt 
eye movement response and the overt arm movement response in a standard peripheral 
pointing task (Desmurget et al., 2001; Johnson-Frey, 2003; Prablanc & Martin, 1992). 
Ultimately, this delay translates into the gaze arriving at the target at approximately the same 
time as hand movement begins. However, it is critical to note that the initial EMG discharge 
for the eye and the hand is nearly synchronous (Biguer et al., 1982; Jeannerod, 1988). 
Increased latencies for the arm compared to the eye are reasoned to be attributable to 
increased inertial forces, rather than an actual delay in sensorimotor processing. This serial 
organization of the ocular-motor response helps explain how and why actions are modified 
online. In contrast to traditional theories of motor control, the hybrid model of online motor 
control posits an integrated two-step process (Desmurget & Grafton, 2000; Hoff & Arbib, 
1993; Pélisson et al., 1986; Prablanc & Martin, 1992). First, a crude motor program for the 
arm, based on perifoveal information, is generated prior to limb movement onset. Given that 
this initial motor command is generated based on an imperfect approximation of the target 
position, it might only function to rapidly drive the effector into the general vicinity of the 
target. Once the primary ocular saccade has reached the target, the arm movement begins. 
Thus, to refine the action and optimize control, the arm’s motor plan can be automatically 
updated online, after movement initiation, based on the new and improved foveal 
information.  
Similarly, in the context of the ‘double-step’ paradigm, the central nervous system 
will continue to parse the visual scene and integrate novel information in accordance with 
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unexpected changes in task demands. In-flight modifications can be derived from a predictive 
feed-forward model of where the limb position should be relative to the target (Wolpert et al., 
1995), to avoid inherent delays associated with sensory processing. When there is an 
unexpected change in target position, there will be a significant disparity between the actual 
and predicted sensory outcome of an ongoing action. An error signal will be detected and 
translated into a motor command aimed at adapting patterns of muscle activation to minimize 
the discrepancy. These adaptations in muscle activity proceed in a similar manner for double-
step movements as they do for single-step movements. Changes in EMG activity occur 
approximately 100 ms after target perturbation and such EMG bursts precede actual 
deviations in limb kinematics (Fautrelle et al., 2010). It is through feed forward specification 
of motor commands and continuous feedback loops that the motor system is able to generate 
online corrections within ~150 ms of target displacement (Brenner & Smeets, 1997; 
Gritsenko et al., 2009; Izawa & Shadmehr, 2008; Paulignan et al., 1991; Prablanc & Martin, 
1992; Soechting & Lacquaniti, 1983). Such rapid, real-time adjustments far surpass the 
temporal rates associated with sensory processing alone, which can often exceed ~250 ms 
(Frith et al., 2000). 
1.1.3 Automaticity of Online Corrections - ‘The Automatic Pilot’ 
Over the last few decades, accumulating evidence has prompted the online corrective 
system to be notably referred to in the literature as the hand’s ‘automatic pilot’. A variety of 
studies support the notion that online corrections involve little if any conscious iterative 
control (Day & Lyon et al., 2000; Diedrichsen et al., 2004; Johnson et al., 2002; McIntosh et 
al., 2010; Pisella et al., 2000). Online modifications in reach trajectories have been shown to 
occur well before the time at which the participant reports consciously perceiving these 
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adaptations. For example, Castiello et al. (1991) showed that limb trajectories could be 
modified within 120 ms of target perturbations – whereas it took participants greater than 400 
ms to vocalize their conscious perception of the target jump. This lag was interpreted to 
reflect an inherent delay between action and perception, rather than simply an increase in the 
time needed to generate a vocal response. Moreover, it is well accepted that limb 
modifications can occur even in the absence of a conscious awareness of both one’s own 
reach amendments and/or perturbations in target position. That is to say, the hand can be 
guided to a new target position regardless of any conscious perceptual awareness of the 
change and independent of intention. This has best been studied through the use of Goodale 
et al.’s (1986) modification of the traditional double-step design. Here, instead of a target 
perturbation being elicited at hand movement onset, a small target displacement was 
triggered while the participant performed their initial eye movement to the first appearing 
target. Although participants lacked a conscious awareness of the target being displaced, their 
hand trajectories appropriately diverged away from their original path to reach the new target 
position, without any additional delay. It was suggested that the participants’ failure to 
perceive the second target displacement reflected the naturally occurring ‘fine-tuning’ of the 
human ocular system. Primary saccades often undershoot a target’s position and require the 
refinement of a subsequent corrective saccade to accurately bring the target of interest 
directly onto the fovea. Therefore, triggering a relatively small target displacement (~10% of 
the movement amplitude) during the primary saccade would induce the same post-saccadic 
refinement as would occur in a single-step trial. The apparent correction that would occur due 
to the target perturbation would simply reflect that which normally follows a primary saccade 
to a stationary target in any case. Other groups have since replicated these findings and have 
suggested that errors can still be efficiently corrected by the motor system, even when these 
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errors are not consciously perceived by the participant (Chua & Enns, 2005; Desmurget et al., 
2001; Pelisson et al., 1986; Prablanc & Martin, 1992). These results not only lend support for 
the automaticity of this corrective response, but also suggest that separate neural pathways 
might mediate perception and action (Milner & Goodale, 1995). 
The notion that double-step-induced online corrections are largely automatic is also 
supported by studies finding comparable limb movement durations (MD) in reaching to 
targets that remain stationary versus to targets that moved to a final location while the action 
was underway. Namely, this online response mechanism results in the participant taking the 
same amount of time to point to a stationary target as it does for them to point to a target that 
ends in the same location, although its initial position had been different when the reaching 
movement was started. Thus, while limb trajectories are being modified to reach a new target 
position, no additional processing time is required. As alluded to earlier, this rapid processing 
indicates that the corrective system might be able to bypass the typical time course required 
for an afferent sensory signal to be translated into an efferent motor command. Furthermore, 
these findings suggest that a new motor command is not being completely reprogrammed, 
but rather online corrections induce rapid automatic modulations of the ongoing response and 
motor programme.  
Although the consensus is that rapid, online corrections suggest a certain level of 
automatic processing, the degree to which these processes operate automatically remains less 
known. To address this knowledge gap, researchers have compared the corrective system 
against two additional standards required for highly automatic processes. First, the action 
should be fairly insensitive to conscious iterative control. That is, online corrections should 
function as ‘hard-wired’ processes that cannot be easily overridden. Compliance with this 
criterion has best been demonstrated in studies where participants are instructed to abort their 
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pointing action upon detection of a target displacement. Most notably, Pisella et al. (2000) 
demonstrated in a significant number of trials that regardless of their intention to do so, 
participants were unable to successfully interrupt their online correction. Furthermore, follow 
up studies have since modified Pisella et al.’s (2000) design by instructing participants to 
point in the opposite direction of a target jump, rather than inhibit or cancel their action 
outright. Comparably, participants were unable to repress motor corrections and reliably 
deviated their trajectory in the direction of the target jump despite the anti-point instruction 
(Day & Lyon, 2000; Johnson et al., 2002). 
The second criterion for automaticity states that the action must remain unaffected by 
simultaneous cognitive load. A typical way to investigate this is through the use of a dual-
task paradigm, in which participants are asked to perform two simultaneous tasks. 
Performing an action during single versus dual task conditions can be compared to 
investigate the efficiency and automaticity of the action. An automatic action should be 
performed equivalently under single or dual task conditions. Using this approach, Liu et al. 
(2008) demonstrated that a simultaneous object identification task interfered with the 
planning of an action, but not the online control of an already initiated action. Consequently, 
it was argued that whereas competing cognitive resources might disrupt the pre-programming 
of an action, online control of an already established action remains unaffected. McIntosh et 
al. (2010) further corroborated these findings by showing that both the speed and accuracy of 
online corrections are unaltered by the simultaneous performance of an auditory 1-back task. 
Collectively, these results have led to conclusions ascribing an extremely high level of 
automaticity and autonomy to online reach corrections.  
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1.1.4 Neural Substrates Involved in Online Motor Control 
In addition to inputs from the extrastriate visual cortex, the posterior parietal cortex 
(PPC) receives input from a variety of other sensory modalities including the auditory and 
somatosensory regions (Fogassi & Luppino, 2005). The PPC’s neuroanatomical connectivity 
and its integrative role concerning spatial representations of the body and target objects in the 
environment render it a prime candidate for specifying online context-dependent motor 
commands (Andersen et al., 1997). Despite the large body of evidence supporting the PPC as 
a well-positioned and likely component of online motor control, less is known about the 
exact nature of the underlying mechanisms mediating its involvement in rapid online motor 
adjustments. The strongest direct evidence comes from studies in patients with PPC lesions 
who exhibit significant impairments in double-step reaching tasks compared to single-step 
tasks. Desmurget et al. (1999) first reported disturbances in in-flight reach adjustments upon 
transcranial magnetic stimulation (TMS) of the left posterior parietal lobe. Similarly, 
MacDonald and Paus (2003) reported that the awareness of self-generated movements was 
disrupted when repetitive TMS was applied over the superior parietal lobe. These results 
have since been supplemented by a clinical case study of a patient with ischemic bilateral 
parietal lesions. This patient demonstrated selective impairments during a double-step 
pointing task requiring online reach adjustments, while retaining the ability to accurately 
point to stationary targets during a single-step condition (Pisella et al., 2000).  More recently, 
Battaglia Mayer et al. (2013) found similar disturbances in reach adjustments upon 
deactivation of the parietal areas through the injection of gamma-aminobutyric acid (GABA)-
A agonists in non-human primates. 
	  	   8	  
 In line with these results, neurophysiological studies have also identified changes in 
PPC activity 150 ms following target displacement and approximately 20 ms prior to changes 
in hand kinematics (Archambault et al., 2009; Archambault et al., 2011). Similarly, in a 
positron emission topography (PET) study, increased activity in the intraparietal sulcus was 
found during a double-step pointing task when compared to a single step task in which no 
online corrections were required (Desmurget et al., 2001). Taken together, the anatomical 
positioning and neurophysiological results have led researchers to hypothesize a fundamental 
role for the PPC as a “neural comparator” in online movement guidance. In this regard, the 
PPC might integrate sensory inflow and motor outflow, thereby computing the motor error 
between the target position and the predicted location of the hand. The PPC identifies to what 
extent the existing motor command is imprecise and how this error can be rectified through 
forward modelling of limb dynamics (Buneo & Andersen, 2006; Desmurget et al., 1999; 
Gréa et al., 2002).  
 Whereas the PPC is thought to be involved in identifying error signals, the anterior 
parasagittal cerebellar cortex is argued to be involved in converting these signals into 
corrective motor commands (Desmurget et al., 2001). Anatomical studies have identified a 
range of diverse connections between the cerebellum and cortical areas, including parietal, 
temporal, motor, and premotor cortices (Ramnani, 2006). It is through these connections that 
the anterior parasagittal cerebellar cortex generates an accurate corrective motor plan in 
response to the neural signals issued by the primary motor cortex. Subsequently, changes in 
muscle activation can be induced to redirect the limb in-flight to a modified trajectory path 
(Bastian et al., 1996; Day et al., 1998; Desmurget et al., 2001). Additionally, a strong line of 
evidence implicates the cerebellum in the feed-forward prediction of sensory consequences 
of movements (Blakemore et al., 2001; Miall et al., 1993). Congruent with these theories, a 
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PET imaging study showed increased activity of the anterior parasagittal cerebellar cortex 
following unexpected disturbances in target position requiring inflight reach amendments 
(Desmurget et al., 2001). 
More recently, sub-cortical structures, including the basal ganglia, have been 
implicated in online motor control. The basal ganglia are a collection of subcortical nuclei, 
including the striatum as the input region, and the globus pallidus and substantia nigra 
reticularis (SNr) as the output regions, which have been extensively implicated in motor and 
cognitive functions (Blandini et al., 2000; DeLong, 2000; Graybiel, 2000; Parent & Hazrati, 
1995). Scarce support for the basal ganglia in online motor control has primarily stemmed 
from clinical studies investigating patients with basal ganglia disorders, such as Huntington’s 
disease (HD) and Parkinson’s disease (PD). Smith et al. (2000) first reported that patients 
with HD have a diminished capacity to adapt their actions online in response to large, 
externally applied perturbations to their moving limb. It is important to note that in addition 
to basal ganglia degeneration, HD patients also suffer from significant cortical atrophy, 
which makes interpretation of their data difficult (Ciarmiello et al., 2006; Hedreen et al., 
1991; Rosas et al., 2008). In contrast, studies in early PD are more specific tests of basal 
ganglia involvement in online motor control, given a significant and specific biochemical 
deficit to the striatum, compared to relative sparing of the cortex (Halliday et al., 2011; 
Hornykiewicz, 1998; Jellinger, 1991). Currently, to our knowledge, few studies have 
reported PD-related impairments in iterative online motor control in response to both target 
errors and execution errors (Desmurget et al., 2004; Tunik et al., 2004). The role of the basal 
ganglia in online motor control is further complicated by inconsistent results from 
neuroimaging studies. Diedrichsen et al. (2005) revealed increased striatal (i.e., putamen and 
caudate nuclei) activity exclusively during online corrections induced by target 
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displacements, whereas no such elevation in striatal activity was reported for execution errors 
induced by mechanical limb perturbations. In contrast, other groups reported augmented 
basal ganglia activity only during the ‘pre-movement’ planning phase of self-initiated 
actions, as opposed to during the online execution of the action itself (Elsinger et al., 2006; 
Boecker et al., 2008). Furthermore, clinical reports speculate that the basal ganglia are 
involved in striatal-dopamine-mediated correction of trial-to-trial errors. The ambiguous use 
of the term “error correction” has perhaps resulted in unwarranted support for the basal 
ganglia in the automatic control of the in-flight error corrective system. Critically, Smith & 
Shadmeh (2000) have highlighted that it is essential to distinguish between the different 
mechanisms for adjusting to errors online compared to adapting to errors identified through 
trial-to-trial learning. Second, reports cite that patients with PD not only use visual feedback, 
but might actually rely more heavily on this visual information during reaching or pointing 
tasks. Increased reliance on continuous visual information might be an alternative strategy 
used to help compensate for PD-related deficits in the pre-programming of a motor plan 
(Flash et al., 1992; Klockgether et al., 1994). In theory, if the basal ganglia are truly 
implicated in online control, then dysfunction of this neural region should significantly 
disturb the use of visual feedback loops during an ongoing action. In subsequent chapters, I 
will further elaborate on online motor control in PD, along with the myriad of factors that 
possibly confound interpretation of previous work that has supported impairments in this 
function in this disease.  
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1.2. Parkinson’s Disease  
1.2.1 Parkinson’s Disease Pathology & Aetiology 
PD is the second most common neurodegenerative disorder worldwide. A central 
pathological change in PD, giving rise to its most recognizable motor symptoms, comprises 
the substantial degeneration of dopaminergic neurons in the substantia nigra pars compacta 
(SNc) and, to a much lesser extent, in the ventral tegmental area (VTA). To understand the 
neuropathology of PD, it is first important to review normal basal ganglia circuitry. The basal 
ganglia are a collection of sub-cortical nuclei situated at the base of the prosencephalon. The 
striatum is the principal input structure of the basal ganglia, receiving afferent projections 
from virtually all functioning regions of the cerebral cortex, the thalamus, the SNc and the 
VTA. Cortico-striatal connections are functionally and topographically divided and provide 
excitatory glutamatergic input to the striatal medium spiny neurons (MSNs). In turn, the 
MSNs project to the two major output components of the basal ganglia, the globus pallidus 
and the SNr, through a direct and indirect pathway respectively. The striatal output of both 
pathways is inhibitory, with GABA being the principal neurotransmitter of the output 
streams. The pallidal complex and the SNr, in turn, provide inhibitory outputs to the 
thalamus, which then projects back, via excitatory connections, to the cortex. The direct and 
indirect basal ganglia pathways have antagonistic effects on thalamic and thus, target cortical 
structures. Excitation of the direct pathway results in net excitation of thalamic neurons, 
whereas excitation of the indirect pathway results in net inhibition of thalamic neurons 
(Alexander et al., 1986; Gerfen, 1996; Graybiel, 2000; Gurney et al., 2001; Haber, 2003; 
Haber & Calzvara, 2009; McHaffie et al., 2005; Parent, 1990; Parent & Hazrati, 1995). The 
thalamus has excitatory connections to the cortex and in this way the direct pathway 
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Figure 1. Model of Normal Basal Ganglia Circuitry. Neurons expressing D1-
class dopamine receptors form the excitatory direct striatonigral pathway, whereas 
neurons expressing D2-class dopamine receptors form the inhibitory indirect 
striatonigral pathways. The output of the basal ganglia is dependent on the balance 
between both the direct and indirect pathways. Solid lines represent excitatory 
projections and dashed lines represent inhibitory projections. Adapted from Lewis 
et al. (2003).  
enhances cortical activity whereas the indirect pathway depresses it.  Connectivity of the 
indirect and direct pathways is illustrated in Figure 1.  
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 The direct and indirect basal ganglia pathways are modulated through dopaminergic 
striatonigral projections. Critically, there is differential expression of D1 and D2-class 
dopamine receptors in each of these two streams. MSNs in the direct pathway have high 
levels of D1-class receptors, which depolarize the neuron in response to dopamine. In 
contrast, the MSNs in the indirect pathway predominately express D2-class receptors, which 
hyperpolarize the neuron in response to dopamine. The functional antagonism between D1 
and D2-class receptors translates into heightened dopamine levels stimulating the direct 
pathway, while simultaneously inhibiting the indirect pathway. Together, increased striatal 
dopamine results in an overall reduction in GPi and SNr activity and consequently an overall 
increase in thalamic and cortical activity (DeLong et al., 2007; Graybiel, 2000; Smith et al., 
1998; Utter & Basso, 2008).   
An appropriate balance between both the direct and indirect basal ganglia pathways is 
integral for proper psychomotor functioning. When this balance is interrupted, discharge 
patterns in the basal ganglia become abnormal and movement disorders prevail. In the case of 
PD, the SNc suffers the greatest dopaminergic neuron loss compared to other basal ganglia 
nuclei (Fahn, 2003; Greenfield & Bosanquet, 1953; Jellinger, 1991; Tanner & Goldman, 
1996). Degeneration of the striatonigral dopaminergic pathway increases neuronal activity in 
the GPi and the SNr, and consequently results in over-inhibition of thalamo-cortical and 
brainstem motor systems (Transm, 1995). The hallmark features of PD – including poverty of 
voluntary movements and resting tremor – are primarily owed to excessive inhibition of these 
neural regions.  
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1.2.2 Symptomology of Parkinson’s Disease 
Striatal dopamine depletion leads to the predominant motor features of PD, including 
early bradykinesia, rigidity, resting tremor, as well as later postural and gait abnormalities. 
These early, main motor characteristics almost always present unilaterally at onset, though 
they eventually become bilateral with disease progression. Bradykinesia refers to slowness in 
movement and often occurs in conjunction with reduced spontaneous and hypometric 
movements, termed akinesia or hypokinesia. Bradykinesia can manifest as increased motor 
reaction times (RT), decreased acceleration, and reduced movement velocities. Such 
movement abnormalities have been suggested to arise due to a central deficit in the planning 
phase of motor control (Berardelli et al., 2001). In other words, deficits in pre-programming 
of motor plans are postulated to produce difficulties initiating movements and maintaining 
consistent force and speed (Sheridan et al., 1987).  
Although primarily characterized by motor symptoms, non-motor symptoms are also 
commonly present in PD and include neuropsychiatric (Aarsland et al., 1999; Aarsland et al., 
2009; Chaudhuri et al., 2009), cognitive (Dubois & Pillon, 1996; Green et al., 2002; 
Jankovic, 2008; Owen et al., 1992), autonomic (Goetz et al., 1986; Wakabayashi & 
Takahashi, 1997), gastrointestinal (Edwards et al., 1992; Pfeiffer, 2003), sensory, (Ansari & 
Johnson, 1975; Snider et al., 1976; Ward et al., 1983;) and sleep disturbances (Comella, 
2003; Menza et al., 2010). The most prevalent neuropsychiatric complaints include 
depression (McDonald et al., 2003; Slaughter et al., 2001; Reijnders et al., 2008), anhedonia 
(Isella et al., 2003), apathy (Pluck & Brown, 2004) and anxiety (Richard et al., 1995; Stein et 
al., 1990).   
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1.2.3 Symptomatic Treatment of Parkinson’s Disease 
Currently, there is no cure for PD. Dopamine replacement therapy replenishes 
dopamine in the striatum, alleviating motor and some cognitive impairments. Oral 
administration of L-3, 4-dihydroxyphenylalanine  (levodopa), a precursor to dopamine, 
remains the primary treatment of choice. Levodopa is decarboxylated after passing through 
the blood brain barrier, enabling it to act directly on dopamine receptors within the brain. 
Commonly, levodopa is administered in conjunction with peripheral decarboxylase 
inhibitors, such as carbidopa, to prevent the decarboxylation of levodopa to dopamine prior 
to crossing the blood brain barrier. 
Despite the known efficacy of levodopa in improving certain motor symptoms, its 
effects on cognitive functions have proven to be somewhat paradoxical. Increasingly, 
levodopa has been recognized to improve certain domains, while impairing functioning in 
others. Such inconsistent findings have been attributed to uneven dopaminergic cell depletion 
across the SNc and VTA respectively. The SNc, which innervates the dorsal striatum (i.e., 
bulk of caudate nuclei and putamen), experiences profound dopaminergic neuron loss. In 
contrast, the VTA, which innervates the ventral striatum (i.e., nucleus accumbens, ventral 
putamen and ventral caudate), remains relatively spared from such cell death (Fearnley & 
Lee, 1991; Goto et al., 1989; Hirsch et al., 1988). Therefore, dopamine replacement 
therapeutics might help restore dopamine levels in depleted neural regions like the dorsal 
striatum, but might detrimentally ‘overdose’ less affected neural regions such as the ventral 
striatum. Accordingly, functions mediated by the dorsal striatum, such as cognitive flexibility 
and motor control, are thought to improve with dopaminergic therapy (Cools & D’Esposito, 
2011; Robbins & Everitt, 1992), whereas certain cognitive tasks, such as probabilistic 
associative learning and impulsive responding, mediated by VTA-innervated brain regions 
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are thought to become impaired (Cools et al., 2001; Jahanshahi et al., 2010; MacDonald & 
Monchi, 2011). That is, overdose effects in PD could be due to exogenous dopamine therapy 
distributing to relatively dopamine replete brain regions (i.e., those innervated by VTA) as 
well as to intended regions that are significantly dopamine depleted (i.e., mainly dorsal 
striatum innervated by SNc). Nevertheless, these findings do not clarify whether these 
changes in performance are due to a main effect of dopamine medication or if they are due to 
a PD by medication interaction. To circumvent this ambiguity, the effect of levodopa on 
performance in healthy controls, who presumably have optimal baseline levels of 
endogenous dopamine, has been investigated (Cools & Esposito, 2011; Flöel et al., 2005; 
Rihet et al., 2002; Shellshear et al., 2015; Vo et al., 2015). Such an experimental 
manipulation allows the effects of dopaminergic medication to be investigated in a way that 
is unconfounded by PD-related pathology. Moreover, it helps facilitate our understanding 
surrounding the effects of excessive ventral striatal dopamine. 
1.2.4 Online Motor Control in Parkinson’s Disease 
 
Although it is well established that PD disrupts certain motor domains, especially 
those associated with the pre-programming of a movement (Harrington & Haaland, 1991), 
far less is known about how patients with PD control actions that are underway. To the best 
of our knowledge, surprisingly few studies have directly examined online motor control in 
PD. Tunik et al. (2004) developed a postural trunk-perturbation paradigm, in which controls 
and patients with PD were instructed to touch their finger to their nose while their trunk 
position was unexpectedly perturbed. Unexpected perturbations in trunk position required the 
participants to adapt their upper-limb motor plans to smoothly and accurately complete the 
finger-to-nose action. Here, they found that PD patients were significantly impaired in the 
	  	   17	  
perturbed trunk condition, as revealed by these patients having segmented trajectory paths, 
increased MDs, and irregular velocity profiles. The authors interpreted these findings as 
evidence that basal ganglia dysfunction leads to deficits in the flexibility of responses to 
amended motor states.  
Critically, the neural correlates and mechanisms for adjusting to “execution errors” 
and “target errors” are distinct. Despite both errors inducing similar online corrective 
responses, they rely on fundamentally different computational strategies (Diedrichsen et al., 
2005). As such, one should be hesitant to compare these results to those of online corrections 
to visual targets, as is assessed using a double-step paradigm. Indeed, in a traditional double-
step experiment, PD patients did not demonstrate any deficits in adjusting their hand 
trajectories in response to subliminal, small target jumps occurring during their initial 
saccades (Desmurget, 2004). In contrast, in a separate follow up experiment, Desmurget et al. 
(2004) showed that although PD patients could consciously perceive a target displacement, 
they failed to adequately modify their ongoing trajectories when that target’s location was 
largely displaced at hand movement onset. These two findings guided the current 
interpretation that whereas PD patients are impaired in consciously-mediated automatic 
online motor control, they retain the ability to perform subconscious automatic online motor 
adjustments.  
Critically, a finding of impaired automatic online processing in PD directly 
contradicts the predominant notion that the dorsal striatum is responsible for suppressing 
automatic behavioral responses. That is, the current literature suggests that dysfunction of the 
dorsal striatum leads to increased interference from salient stimuli and consequently greater 
automaticity in behavioral responses (Benke et al., 2003; Cameron et al., 2010; Cools et al., 
2006; Cools et al., 2010; Rieger et al., 2003; Thoma et al., 2008). During cognitive 
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assessments, such as the Stroop task, PD patients reveal a greater tendency to perform the 
automatic response of reading the word rather than the more cognitively controlled response 
of naming the color (Brown & Marsden, 1988; Dujardin et al., 1999; Henik et al., 1993). 
Likewise, using a stop-signal paradigm Rieger et al. (2003) showed increased stop signal RTs 
in patients with striatal lesions relative to their control counterparts, indicating a role of the 
striatum in the volitional control of an ongoing response. These results are further 
corroborated by functional magnetic resonance imaging (fMRI) paradigms, which have 
demonstrated greater dorsal striatal activity in conditions with increased interference (Ali et 
al., 2010; Liu et al., 2010). For instance, dorsal striatal activity has been shown to increase 
when participants are required to provide a less-practised or less automatic response, such as 
naming a picture in their second language relative to their first language (Liu et al., 2010).  
Moreover, these findings extend to psychophysical paradigms, such as the anti-saccade task, 
which instructs participants to look in the opposite direction of an appearing visual stimulus. 
This paradigm requires participants to not only supress the automatic pro-saccade, elicited by 
the external visual stimulus, but also generate a volitional saccade via an internal command. 
Unsurprisingly, PD patients commonly demonstrate robust impairments in this task, as 
indicated by increased RTs and a greater inability to suppress pro-saccades in the direction of 
the target (Briand et al., 1999; Kitagawa et al., 2004; Van Koningsbruggen et al., 2009). In 
contrast, in pro-saccade tasks that instruct participants to look towards the sudden appearing 
target, participants with PD perform this automatic orienting response normally (Briand et al., 
1999;) and in some cases even better than controls (Armstrong et al., 2002; Chan et al., 
2005). Although, the effects of consciousness have yet to be directly investigated on 
automatic action in PD, results from the Stroop task and pro-saccade task indicate that 
automatic function can in fact rely on consciously perceivable visual cues. Consequently, the 
	  	   19	  
finding that patients with PD are impaired at online automatic motor control when 
adjustments are conscious is not expected from the literature.  
In light of this broader literature, the finding by Desmurget et al. (2004) that PD 
patients were impaired in automatic online motor corrections, when the need to perform a 
correction was consciously perceived, was somewhat unforeseen. On further consideration, 
aspects of Desmurget’s experimental setup, unrelated to the consciousness of the corrective 
action, might have differentially impacted PD patients’ performance relative to that of their 
control counterparts. In particular, in the experiment where the need for a corrective action 
became consciously perceived, the timing of the target jump was linked to movement onset. 
Bradykinesia, a cardinal motor symptom, causes PD patients to take longer to initiate actions.  
Therefore, when target perturbations occurred at movement onset, this target jump and 
change in the movement trajectory would occur later for PD patients compared to their 
controls. PD patients would therefore have an increased time to prepare their movement 
toward the initial target position. That is, PD patients would exhibit an increased preparatory 
phase to plan their preliminary action before the target is unexpectedly displaced (See Figure 
2). This is particularly problematic because it has been shown that longer preparatory phases 
for an action lead to greater challenges in later modifying or inhibiting that action (Lappin & 
Eriksen, 1966; Logan, 1981). It is important to note that in contrast to target perturbations at 
limb movement onset, target jumps elicited during a saccade would not alter the preparatory 
phases between groups because PD patients and controls have similar pro-saccade onset 
latencies and durations. Therefore, only in the experiment probing conscious online motor 
control, where the target displacement was linked to limb movement onset, would the 
preparatory phases have been increased for the PD patients relative to the healthy controls. 
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Given this confound, the mechanism underlying impairments in online motor control for PD 
patients observed by Desmurget in the double-step paradigm remains unclear.  
1.3 The Current Study 
1.3.1 Rationale for Current Study 
 
 In Desmurget et al. (2004), PD patients were impaired in altering their hand-
movement trajectories when target displacements occurred at hand-movement onset, but not 
when target perturbations occurred during the saccade using the classic double-step 
Figure 2. Schematic of a Hypothetical Timeline for Target Displacement at Hand 
Movement Onset for (1) healthy controls and (2) PD patients. The red line represents 
the preparatory phase towards the initial target location. 	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paradigm. Traditionally, when target jumps occur at hand-movement onset, they are 
consciously perceived, in contrast to when they occur during a saccade. Due to disease-
associated bradykinesia, however, target jumps that occur at hand-movement onset also 
produce longer action preparation phases toward the initial reach target in PD patients 
compared to controls. Indeed movement onset latencies, and hence the preparation of the 
movement trajectory that ultimately had to be revised, were on average 120 ms longer for PD 
patients compared to controls. Consequently, the interpretation of Desmurget’s pattern of 
results is confounded. These results could reflect impairments for PD patients for automatic 
online movement adjustments when the need for this alteration is consciously perceived as 
Desmurget has argued. Equally possible, however, this pattern of findings could have arisen 
because PD patients had an increased preparatory phase for the initial target reach trajectory 
relative to the preparatory phase of controls. It has been shown that longer preparatory phases 
for actions leads to greater challenges in later modifying or inhibiting those actions (Lappin 
& Eriksen, 1966; Logan, 1981). This introduced a significant, unintended disadvantage for 
PD patients that alone could account for their deficient performance. The aim of the current 
study was to directly contrast automatic online motor corrections that were unconscious 
versus conscious, eliminating conditions that would disadvantage PD patients owing to their 
motor symptoms.    
1.3.2 Objective  
The main objectives of the present study are two-fold. First, we aimed to develop a 
double-step paradigm that directly dissociated perceptual awareness of a target displacement 
from potential confounding effects of PD-related bradykinesia. Second, using our adapted 
paradigm, we aimed to explicitly elucidate the effects of conscious-iterative control on 
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automatic online motor adjustments in patients with PD and healthy controls. Taken together, 
we aimed to systematically consider how PD-related bradykinesia might have confounded 
the previous approaches used to investigate automatic online motor control with and without 
conscious perception. Furthermore, this research aimed to provide insight into the role of the 
basal ganglia in online motor control at the behavioral level. 
1.3.3 Predictions 
An alternative explanation for previously observed PD-related impairments in 
conscious online corrections lies in the assumption that the preparatory phase timing affects 
one’s ability to perform rapid online motor adjustments. In line with this, we predicted that 
when confounding effects of bradykinesia are accounted for (i.e. the preparatory phase is 
equalized between PD patients and healthy controls) that the two groups will perform 
consciously-perceivable online corrections more similarly. We predicted that corrections 
made in response to either consciously-perceived or subliminal target jumps will not 
significantly differ for patients with PD and healthy controls.  
Chapter 2: Methods 
2.1 Participants 
This study included 12 patients with clinically diagnosed idiopathic PD and 12 
healthy age-matched controls. All participants provided written and informed consent 
according to the Declaration of Helsinki (1991) and all procedures were approved by the 
Health Sciences Research Ethics Board of the University of Western Ontario (London, 
Ontario, Canada). Participants did not have previous experience with the task, were naïve to 
the purpose of the experiment and were right-handed. Controls had no history of neurological 
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illness, major psychiatric disorder, motor deficits or head trauma. Additionally, healthy 
controls were not taking any cognitive-enhancing medications and had no history of 
substance abuse. All participants had normal or corrected-to-normal vision. A complete list 
of inclusion criteria is included in Appendix H. The age of PD patients (M = 64.83, SD = 
9.41) and the age of controls (M = 65.0, SD = 8.62) did not significantly differ. In addition, 
controls were matched to PD patients for education. A complete outline of population 
demographics is included in Table 1.  
Patients with PD were all levodopa responsive and were taking dopaminergic 
medication at the time of testing. The daily levodopa equivalent dose (M = 673.2 mg, SD = 
356.67) was calculated in accordance with Evans et al. (2004): levodopa dose + levodopa x 
1/3 if on entacapone + bromocriptine (mg) x 10 + cabergoline or pramipexole (mg) x 67 + 
ropinerole (mg) x 20 + pergolide (mg) x 100 + apomorphine (mg) x 8.  PD patients did not 
report any cognitive complaints and were all found to be cognitively unimpaired in 
accordance with the standard MoCA examination (M = 27.33, SD = 1.37). Patients and 
controls were excluded if they scored less than 25/30 on the MoCA. Furthermore, patients 
had no history of any additional neurological illnesses unrelated to PD, had no suspicion of 
familial forms of PD, had no history or current treatment with deep brain stimulation and 
were not taking any cognitive-enhancing medications.   
All patients participated in two identical testing sessions on separate days: once while 
taking their usual dopaminergic therapy as prescribed by their treating neurologist, and once 
following withdrawal from dopaminergic medication. In the Off dopamine session, patients 
were instructed to abstain from taking all dopaminergic medications including dopamine 
precursors such as levodopa, aromatic-L-amino-acid decarboxylase inhibitors such as 
carbidopa, and catechol-O-methyltransferase (COMT) inhibitors such as entacapone for a 
	  	   24	  
minimum of 12 to a maximum of 18 h, and dopamine agonists, such as pramipexole 
(Mirapex), ropinirole (Requip) or pergolide (Permax), as well as amantadine (Symmetrel), 
rasagiline (Azilect), and selegiline (Eldepryl or Deprenyl) for 16–20 h prior to testing.  
Similarly, all healthy controls participated in two distinct testing sessions, examining 
the effects of dopamine medication (100 mg levodopa + 25 mg carbidopa, orally) versus 
placebo (identical cornstarch placebo) on separate days. Healthy participants were thoroughly 
screened using the Levodopa Safety Screening Questionnaire prior to their participation 
(Appendix I). Administering levodopa to healthy controls allowed us to directly investigate 
the effects of this medication independent from any PD pathology on online motor control. 
All On-Off medication orders were counterbalanced across participants and the On-Off order 
was identical for each PD patient and his/her age- and education-matched healthy control 
participant.  
The presence and severity of PD symptoms was assessed for each patient, both on and 
off dopaminergic medication, using the Unified Parkinson’s Disease Rating Scale (UPDRS) 
Motor Subscale. Control participants were also assessed using the UPDRS to screen for any 
undiagnosed motor or neurological illnesses. All participants completed a series of 
standardized cognitive and affective screening tests (Appendix C- G). The mean cognitive 
and affective screening scores and the UPDRS motor subscale scores are included in Table 1. 
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Table 1. Demographic, clinical information, and screening cognitive and affective 
measures for participants with PD and controls 
 
 
Values are presented as group means (SEM). Screening cognitive and affective measures were 
completed by participants with PD on medication and by healthy controls off medication. All control 
participants presented with normal neurological exams. Session 1 refers to the first day of testing. 
Session 2 refers to the second day of testing. Edu, years of education; Duration, years since diagnosis 
of PD; Levodopa dose, equivalent dose in mg; UPDRS, Unified Parkinson's Disease Rating Scale; 
Group Age Edu Duration Levodopa 
Dose 
UPDRS     ANART  BDI-II BAI Apathy MOCA 
Day 1            
PD  
(n=12) 
64.83 
(2.72) 
15.67 
(0.99) 
6.58 
(1.37) 
673.21 
(102.9) 
— — 10.67 
(1.29) 
8.92 
(1.50) 
10.92 
(1.15) 
—  
On 
(n=6) 
62.00 
(4.18) 
15.17 
(1.57) 
7.00 
(1.89) 
632.00 
(125.77) 
9.20 
(1.85) 
126.09 
(2.30) 
9.17 
(2.02) 
6.50 
(2.45) 
9.00 
(0.82) 
27.50 
(0.72) 
 
Off 
(n=6) 
67.66 
(3.43) 
16.17 
(1.30) 
6.17 
(2.15) 
714.42 
(173.63) 
12.42 
(2.03) 
— 12.17 
(1.51) 
11.33 
(2.39) 
12.83 
(1.92) 
—  
Control 
(n=12) 
65.00 
(2.48) 
15.92 
(0.88) 
— — — — 2.75 
(0.70) 
2.75 
(0.93) 
9.17 
(1.02) 
—  
On 
(n=6) 
65.66 
(4.07) 
16.83 
(1.11) 
—       — 0.167 
(0.167) 
— 3.83 
(0.91) 
2.17 
(0.87) 
7.83 
(1.60) 
—  
Off 
(n=6) 
64.50 
(3.28) 
15.00 
(1.36) 
— — 0.00 127.47 
(2.08) 
1.67 
(0.92) 
3.33 
(1.71) 
10.50 
(1.15) 
28.5 
(0.43) 
 
Day 2             
PD 
(n=12) 
64.83 
(2.72) 
15.67 
(0.99) 
6.58 
(1.37) 
673.21 
(102.9) 
— — 10.58 
(1.59) 
7.42 
(1.29) 
11.42 
(1.67) 
—  
On 
(n=6) 
67.66 
(3.43) 
16.17 
(1.30) 
6.17 
(2.15) 
714.42 
(173.63) 
10.83 
(2.21) 
128.65 
(1.29) 
12.67 
(2.72) 
8.00 
(2.31) 
15.17 
(2.18) 
27.17 
(0.40) 
 
Off 
(n=6) 
62.00 
(4.18) 
15.17 
(1.57) 
7.00 
(1.89) 
632.00 
(125.77) 
12.0 
(2.00) 
— 8.50 
(1.45) 
6.83 
(1.35) 
7.67 
(1.38) 
—  
Control 
(n=12) 
65.00 
(2.48) 
15.92 
(0.88) 
— — — — 2.67 
(0.49) 
2.50 
(1.09) 
8.75 
(1.12) 
—  
On 
(n=6) 
64.50 
(3.28) 
15.00 
(1.36) 
— — 0.00 — 2.17 
(0.65) 
3.17 
(2.01) 
11.17 
(1.05) 
—  
Off 
(n=6) 
65.66 
(4.07) 
16.83 
(1.11) 
— — 0.00 126.42 
(1.79) 
3.17 
(0.75) 
1.83 
(1.01) 
6.33 
(1.45) 
27.833 
(0.65) 
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ANART, National Adult Reading Test IQ Estimation; BDI-II, Beck Depression Inventory II score; 
BAI, Beck Anxiety Inventory I score; Apathy, Apathy Evaluation Scale score; MoCA, Montreal 
Cognitive Assessment measured for participants with PD and for matched control participants. 
2.2 General Design 
 
A modified double-step, pointing paradigm was employed. The premise of the task 
remained the same: participants were instructed to point to a peripheral visual target, which 
depending on the trial, either remained stationary or unexpectedly changed locations. To 
eliminate any confounding effects of bradykinesia, in one condition, we induced online, 
automatic motor corrections that were consciously perceived in a way that was independent 
of hand movement initiation compared to another condition in which these perturbations 
were not consciously noted. To this end, we introduced two sizes of target perturbations: 
small (3.5 cm) and large (7 cm), both of which occurred during the initial saccade. Given that 
visually-guided saccades have not previously been shown to be delayed in PD (Armstrong et 
al., 2002; Briand et al., 1999; Chan et al., 2005), introducing a target displacement during this 
time would render the initial preparatory phase equivalent for PD patients and healthy 
controls. Furthermore, by modifying the target jump size, we expected small perturbations to 
fall below the threshold for conscious perceptual awareness, whereas the larger perturbations 
would exceed the threshold for awareness (Goodale et al., 1986; Pélisson et al., 1986). To 
confirm that this method was effective, participants began and ended each session with a 
two-alternative forced choice task in which we directly assessed their conscious perceptual 
awareness of the target displacements.  
2.3 Apparatus and Stimuli 
Participants sat at a table in a darkened room with their head stabilized in a chin-rest. 
A pressure-sensitive start button was fastened to the table directly in front of the participant 
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and approximately 10 cm from the edge of the tabletop. The stimuli were presented on a 
vertically mounted custom-built display board. The board consisted of a horizontal array of 
red light emitting diodes (LEDs) set below a transparent Plexiglas surface. Each LED was 5 
mm in diameter. The board was secured to the table such that the leftmost LED, which 
functioned as the fixation point, was positioned at the midline 40 cm in front of the subject 
and aligned with the start button. All other LEDs served as targets and were horizontally 
aligned at 7 distances to the right of the fixation point:  24.5, 28, 31.5, 35, 38.5, 42, 45.5 cm 
(See Figure 3).  These targets are referred to as T1-T7 respectfully. 
Infrared-light emitting diodes (IREDs) were attached to the participant’s right index 
finger and inner wrist with adhesive tape. The experimenter ensured that the pad of the 
participant’s index finger was unobstructed. The diode wires were secured to permit 
unrestricted arm movements. The 3D positions of the IREDs were recorded with an 
optoelectronic motion capture system, Optotrak Certus (Northern Digital, Waterloo, ON, 
Canada) at 200 HZ. Monocular eye position was recorded at 1000 HZ with the Eyelink 1000 
table-mount eye-tracking system (SR Research, Mississauga, ON, Canada). The camera lens 
was positioned approximately 60 cm from the participant’s head. The eye tracker was 
calibrated for every participant, and drift correction was routinely performed according to the 
manufacturer’s guidelines and standards. The synchronization between Optotrak and Eyelink 
recordings and the stimuli display board was achieved using custom-designed software. 
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2.4 Procedure 
Experimental procedures were identical in both Session 1 and Session 2. All 
participants performed a target displacement judgment task and a pointing task in a darkened 
room. For both the perceptual judgment and pointing tasks, participants began by staring at a 
central fixation point. As soon as the fixation point was extinguished, an LED light became 
illuminated at one of seven peripheral locations (T1-T7) to act as the target. Participants were 
Figure 3. Schematic of Experimental Setup. The fixation point (FP) and the target 
lights are represented by red circles. Only one red light was illuminated at a time during 
the actual experimental procedure. The participant began each trial with their right 
pointer finger depressed on the start button (SB).  	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instructed to look towards the target as quickly and as accurately as possible. The target 
would either remain stationary or would be unexpectedly displaced by a distance of 3.5 cm or 
7 cm during the participant’s initial orienting saccade. Specifically, on jump trials, target 
displacements were elicited once the saccade reached a velocity threshold of 50 deg/s. Target 
displacements were only initiated from either T3 or T5 locations and could occur either to the 
left or to the right of the original target location (See Figure 4). The distance between each 
target was 3.5 cm, meaning that a small displacement would constitute a jump from T3 to T2, 
T3 to T4, T5 to T4, or T5 to T6, whereas a large displacement would include those directed 
from T3 to T1, T3 to T5, T5 to T3, and T5 to T7. Each target jump type specified by size, 
direction, and starting position, occurred with equal frequency throughout the experiment. A 
detailed description of each condition type is listed in Table 2. For all statistical comparisons, 
analyses of variance (ANOVAs) were considered significant when the p-value, corrected for 
multiple comparisons, was < .05. The specifics of the target displacement judgment task and 
pointing task differed as follows. 
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Figure 4. Schematic of Visual Display for an Example Double-Step Trial. The 
participant begins by staring at the central fixation point. A target will appear in the 
periphery (T3 shown here) and will either remain stationary (single-step condition) or 
will be displaced to the left or to the right, a small or a large distance (double-step 
condition: T3T4 shown here).  	  
FP 
T3 
T4 
First Step 
Second Step 
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Table 2. Detailed description of each condition type 
Targets could either remain stationary or could unexpectedly change location during the initial 
orienting saccade. Initial target position refers to the location of the first LED light illuminated within 
a trial. Final target position denotes the location of reach endpoint. Large target jumps were 7 cm in 
size and small target jumps were 3.5 cm. Direction refers to the laterality of the target jump relative to 
its initial position.  
Trial 
Label 
Type Initial 
Target 
Position 
Final Target 
Position 
Distance From Fixation 
Point to Final Target 
Position (cm) 
Size Direction 
T1 Stationary 1 1 24.5 ---- ---- 
T2 Stationary 2 2 28 ---- ---- 
T3 Stationary 3 3 31.5 ---- ---- 
T4 Stationary 4 4 35 ---- ---- 
T5 Stationary 5 5 38.5 ---- ---- 
T6 Stationary 6 6 42 ---- ---- 
T7 Stationary 7 7 45.5 ---- ---- 
T3T1 Jump 3 1 24.5 Large Left 
T3T2 Jump 3 2 28 Small Left 
T3T4 Jump 3 4 35 Small Right 
T3T5 Jump 3 5 38.5 Large Right 
T5T3 Jump 5 3 31.5 Large Left 
T5T4 Jump 5 4 35 Small Left 
T5T6 Jump 5 6 42 Small Right 
T5T7 Jump 5 7 45.5 Large Right 
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2.4.1 Target Displacement Judgment Task  
Each block of the target displacement judgment task consisted of 16 ‘pairs’ of trials. 
A ‘pair’ of trials was defined as the sequential presentation of a jump and a stationary trial. 
Each trial type was presented 2 times, for a total of 4 trials per type. The pairing of stationary 
and jump trials was randomized and the order of presentation was counterbalanced. 
Following each pair of trials, participants were instructed to verbally report if they thought 
the target had jumped in either “Trial A” or “Trial B”. The percentage of correct responses 
were calculated and compared to chance level. 
2.4.2 Double-Step Pointing Task 
Participants began each trial by depressing a pressure sensitive start button with their 
right index finger and staring at the fixation point for 500-1500ms. Their left hand rested in 
their lap. Upon appearance of the peripheral target, participants were instructed to release the 
start button and point to the final target as quickly and as accurately as possible. The task 
consisted of 222 trials. To prevent any predictive behavior, the target remained static in 57% 
of the trials and was displaced in 43% of the trials. Therefore, each stationary condition was 
presented 18 times, whereas each jump condition was presented 12 times. Jump and 
stationary trials were randomly interspersed and the trial order was randomized across 
participants. The target remained visible for the duration of the movement and extinguished 
when the participant touched it with their pointer finger. Upon touching the target, 
participants were instructed to return their right pointer finger to the start button to initiate the 
next trial (See Figure 5).  
Prior to experimental trials, participants performed a practice block until they became 
comfortable with the task 
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43% of trials 
Fixation point off 
Initial target on 	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Figure 5.  Timeline of Trial Events. Schematic representation of trial events across 
time in the double-step pointing task. Adapted from Johnson & Haggard (2005). 
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2.5 Data Processing and Analyses 
2.5.1 Target Displacement Judgment Task 
To assess perceptual awareness of the target jump, the percentages of correct 
responses for each group and for each jump size were compared to the chance level 50% 
using separate one-sample t-tests. Further, we ran a 2 × 2 × 2 mixed ANOVA with Group as 
the between-subject factor (PD vs. Control) and Dopamine Medication Status (On vs. Off) 
and Target Jump Size (Large vs. Small) as the within-subject factors. The dependent variable 
was percentage of correct responses.  
2.5.2 Double-Step Pointing  
Analyses were performed in two steps. First, we analyzed eye and hand movements 
directed towards stationary targets. Second, we evaluated the effect of target displacement on 
reach kinematics and trajectories. For both steps, the kinematics of each trial were analyzed 
offline. To isolate the dependent variables, we restricted the data set to include only points 
during which the hand was in motion in the forward reach trajectory. Thus, we defined the 
beginning of the movement as the first of 5 consecutive sample frames in which the wrist 
IRED exceeded a threshold velocity of 40 mm/s. We defined the end of the movement as the 
frame with the maximum y-spatial coordinate. If a straight line was drawn between the start 
button and the array of target lights it would represent increasing depth distance (y-axis). 
Therefore, the maximum y-spatial coordinate corresponded to the end position when the full 
reach distance was achieved (i.e. when target was touched).  
The specifics of each analysis are described below. 
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Eye Movements: Stationary Targets  
The variable of interest extracted from the eye tracking data was saccade RT. The 
validity of the experiment was predicated on the premise that saccade RT, and thus timing of 
target perturbation, did not vary across groups. To confirm this, we ran a 2 × 2 repeated 
measures ANOVA with Group as the between-subjects factor (PD vs. Control) and 
Dopamine Medication Status (On vs. Off) as the within-subject factor.  
The saccade of interest was determined as the first saccade greater than 2 degrees that 
occurred after the initial target light became illuminated.  
Kinematic and Reach Trajectories: Stationary Trials 
The following dependent variables were extracted from the kinematic data to evaluate 
performance on stationary trials: hand RT, MD, maximum acceleration, and peak velocity. 
Hand RT was defined as the time it took to release the start button and to initiate the pointing 
movement following the illumination of a peripheral target. MD referred to the time from 
movement onset to reaching the target and therefore movement offset.  
Separate 2 (Group: PD vs. Control) × 2 (Dopamine Medication Status: On vs. Off) 
mixed ANOVAs, with Group as the between-subject factor and Dopamine Medication Status 
as the within-subject variable were performed on the four dependent measures. 
Kinematic and Reach Trajectories: Jump Trials 
The principal dependent measures extracted to assess online corrections were MD 
difference scores and point of divergence. MD difference scores were calculated with the 
following equation: Mean MD Jump Target (A) – Mean MD Stationary Target (B) à Target 
(A).  This value was calculated individually for each participant and for each jump condition. 
This concept can best be illustrated with an example. To determine the MD difference score 
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for when a target first appeared at Position 3 and was subsequently displaced to Position 1 
(i.e. T3T1), the mean MD for the stationary T1 condition would be subtracted from the mean 
MD for the jump T3T1 condition.  
A 2 x 2 x 2 mixed ANOVA was performed with the between-subjects factor as Group 
(PD vs. Control) and the within-subject variables as Dopamine Medication Status (On vs. 
Off) and Target Jump Size (Small vs. Large). We also computed an additional repeated 
measures ANOVA including the within-subject factor Direction (Left vs. Right) to confirm 
that laterality did not have an effect on the dependent variable. 
 Point of divergence was characterized as the frame at which a reach trajectory on 
jump trials diverged away from its original hand path to reach the new target location. To 
determine this point, reach trajectories were first smoothed and normalized in accordance to 
functional data analysis techniques established by Ramsay and Silverman (2002). In brief, for 
each participant, on each trial, trajectories were fitted with 6-order b-splines to the x, y, and z 
spatial coordinates. The data were normalized such that each trajectory was defined at 300 
points equally spaced in the y-dimension. As such, the continuously defined data curve 
constituted a single functional observation, rather than its individual discrete data points 
(Ramsay & Silverman, 2002; Levitin et al., 2007). We conducted a set of planned mixed 
functional ANOVAs to contrast each jump type with its corresponding stationary condition 
(either T3 or T5), across Dopaminergic Medication Status (within-subject: On vs. Off) and 
Group (between-subject: PD vs. Control). Functional ANOVAs were performed in Matlab 
2014 using customized code adapted from http://www.psych.mcgill.ca/misc/fda/. Functional 
ANOVAs extend the uni-variate ANOVA to all points in a trajectory. In this manner, a single 
functional comparison is performed through the implementation of individual repeated 
measures ANOVAs at each frame. Critically, these multiple comparisons do not violate 
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statistical sense as these multiple analyses are only run as a ‘surrogate’ for a single statistical 
comparison of the entire function (Ramsay & Silverman, 2002). We defined the point of 
divergence as the point at which greater than 10 consecutive time points for jump trial 
conditions differed significantly from their respective stationary trial condition at p < 0.05, 
corrected for multiple comparisons. 
Chapter 3: Results 
First, we empirically evaluated the effects of small (i.e., 3.5cm) and large (i.e., 7cm) 
intra-saccadic target jumps on conscious perceptual awareness. Second, to isolate any 
baseline differences between the PD and the control group, we examined ocular and limb 
kinematics directed towards stationary peripheral targets. Lastly, we assessed online motor 
performance in response to large, consciously-perceived, and small, subliminal target 
displacements.  
3.1 Target Displacement Judgment Task: Perceptual 
Awareness Results 
Target jump size had a significant effect on the percentage of correct responses [F (1, 
22) = 221, MSe = 228, p < .001], with greater accuracy resulting for large relative to small 
target jumps.  This confirmed that the size of the intra-saccadic target jump influenced 
conscious perceptual awareness (Figure 6). The main effects of Group and Dopaminergic 
Medication Status, and the Group x Target Jump Size, Group x Dopaminergic Medication 
Status, Dopaminergic Medication Status x Target Jump Size, and Group x Target Jump Size 
x Dopaminergic Medication Status interactions were not statistically significant, all F < 1.  
Overall, participants correctly identified 82.4% of the large intra-saccadic target 
jumps and only 50% of the small intra-saccadic target jumps. One-sample t-tests indicated 
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that accuracy rates for both groups were significantly greater than the 50% chance level for 
large intra-saccadic target jumps [t(11) = 13.827 p < .001 for PD; t(11) = 16.679, p < .001 for 
controls]. In contrast, accuracy rates for both groups did not significantly differ from 50% 
chance level for small intra-saccadic target jumps [t(11) = -0.089, p = 0.534 for PD; t(11) = 
0.104, p = 0.919 for controls].  
 
Figure 6. Percentage of Correct Responses in Target Jump Judgment Two-
Alternative Forced Choice Task. Correct responses are shown as a function of 
target jump size. Means of the percentage of correct responses are collapsed across 
medication status for both groups (nPD=12; ncontrol =12). The error bars reflect 
standard error about the mean. 
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3.2 Saccade RT and Target Jump Timing Results  
A 2 x 2 mixed ANOVA revealed no main effect of Group [F(1,22) = 2.015, MSe = 
2767, p = 0.170] or Dopaminergic Medication Status [F(1,22) = 1.497, MSe = 71.84  p = 
0.234]  on saccade RT. The interaction between Medication Status and Group was significant 
[F(1,22) = 8.999, MSe = 71.84 , p <.05, Figure 7] reflecting a slight decrease in saccade RT 
for controls and a slight increase in saccade RT for PD patients while on dopaminergic 
medication. To follow up, we directly confirmed that the exact timing of the target jump did 
not significantly differ between Groups [F(1,22) = 0.158, MSe = 1162, p = 0.695] or across 
Medication Status [F(1,22) = 1.96, MSe = 137.9, p = 0.180].  Further, these variables did not 
interact [F(1,22) = 1.404, MSe = 137.9, p = 0.249]. This confirmed that equal preparatory 
phases occurred for both groups and across all conditions.   
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Figure 7. Primary Saccade Reaction Time (RT) in Response to Initial Target 
Appearance. RT is presented as a function of dopaminergic medication status for PD 
participants (n=12) and matched controls (n=12). The mean values are presented with the 
error bars reflecting standard error about the mean. 	  
 
3.3 Limb Movement Characteristics: Stationary Trials   
Patients with PD exhibited significantly longer hand RTs [F(1,22) = 4.327, MSe = 
3.15 x 104, p <.05, Figure 8] and significantly decreased peak velocities compared to healthy 
controls [F(1,22) = 4.449, MSe = 2.38 x 105,  p <.05]. However, there was no significant main 
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maximum acceleration [F1,22 = 2.374, MSe = 5.18 X 107,  p = 0.138]. Medication status did 
not significantly affect any of the dependent variables including hand RT, MD, peak velocity, 
and maximum acceleration, all F < 1. Similarly, Medication Status did not significantly 
interact with Group for any of these dependent variables [F(1,22) = 0.580, MSe = 2419, p = 
0.455 for hand RT; F(1,22) = 0.054, MSe = 5.01 x 104, p = 0.819 for MD; F(1,22) = 0.234, 
MSe = 1.55 x 104,   p = 0.633 for peak velocity; F(1,22) = 0.461, MSe = 1.39 x 107 , p = 0.504 
for maximum acceleration]. 	   
3.4 Limb Movement Characteristics: Jump Trials  
A defining trait of automatic online corrections is that they do not increase the overall 
MD. Our results revealed that patients with PD abide by this trend, both when the online 
corrections were consciously perceived and when they were subliminal. Separate t-tests 
indicated that MD difference scores for jump trials minus stationary trials were not 
significantly different from zero for the PD group across any of the condition types [t(11) =  
1.393, p = 0.191 for PD Off Large; t(11) =  -1.047, p = 0.318 for PD Off Small; t(11) =  
0.409, p = 0.690 for PD On Large; t(11) =  1.383, p = 0.194 for PD On Small, Figure 9A]. 
Similar findings were observed in controls, with two notable exceptions. Controls 
demonstrated MD difference scores significantly greater than zero for large target jumps 
while off of dopamine medication [t(11) =  3.071, p < .05)] and for small target jumps while 
on dopamine medication [t(11) =  3.329, p < .01)].  MD Difference scores were not 
significantly different from zero for the control group for any of the other conditions [t(11) =  
1.687, p = 0.120) for Controls Off Small; t(11) =  1.749, p =0.108) for Controls On Large, 
Figure 9B].  
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Critically, the mixed ANOVA revealed that MD difference scores were not 
significantly different between Groups [F(1,22) = 2.179, MSe = 950,  p = 0.154], across 
Dopaminergic Medication Status [F(1,22) = 0.314,  MSe = 829.81, p = 0.581] or Target Jump 
Size [F(1,22) = 0.513, MSe = 2193, p = 0.48]. PD patients and healthy age-matched controls 
exhibited equivalent changes in MD, regardless of conscious versus unconscious perception 
of target jumps or medication status. A significant interaction was only demonstrated 
between Dopaminergic Medication Status and Target Jump Size [F(1,22) = 4.594,  MSe 
=1045 , p <.05], such that participants overall, collapsing across groups, exhibited increased 
MD difference scores for small/subliminal target displacements on relative to off 
dopaminergic medication with no effect on larger target jumps.  
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Figure 8. Primary Hand Reaction Time (RT) in Response to Initial Target 
Appearance. RT is presented as a function of dopaminergic medication status for PD 
participants (n=12) and matched controls (n=12). The mean values are presented with 
the error bars reflecting standard error about the mean. 	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Figure 9. Movement Duration (MD) Difference Scores Compared to Zero. (A) PD 
patients (n=12) (B) Controls (n=12). MD differences are displayed for each medication 
status and target jump size. Participants performed the task in either the On-Off or Off-
On medication orders. The error bars reflect a 95% confidence interval.  
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 As illustrated in Figures 10 and 11, target end-position had a significant effect on 
lateral deviation throughout the reach for both healthy controls and PD patients, regardless of 
medication status. When the target jumped from its original position to the left, a noticeable 
leftward shift in reach direction occurred relative to the magnitude of the displacement. 
Similar patterns in online reach adjustments were observed for rightward target 
displacements. To further investigate this effect, we implemented individual 2 x 2 x 2 mixed 
measures functional ANOVAs to assess pair-wise comparisons between jump trials and their 
relative stay trials across the movement trajectories. Group was the between-subject factor 
(PD vs. Control) whereas Target Condition (Jump vs. Stay) and Dopaminergic Medication 
Status (On vs. Off) were within-subject variables. A functional main effect of Target 
Condition (i.e. Jump vs. Stay) revealed the percentage of the trajectory travelled before the 
two trajectories significantly differed from one another. Furthermore, we examined 
interactions between Group, Medication Status and Target Condition to investigate whether 
these factors and variables jointly or differentially impacted reach divergence. There were no 
significant effects of Group or Dopaminergic Medication Status on divergence scores. 
Half of our jump trials were initiated from T3 and half were initiated from T5. We 
report our divergence analyses relative to this preliminary target position, as divergence was 
based upon relative deviations from the original target trajectory path. For trajectories 
initially directed to T3, large target displacements had a relatively early effect on reach 
trajectories, such that a smooth divergence was noted at 16% and 26% into the total y-
movement for T3T1 and T3T5 trials respectively. This divergence from stay trials was 
maintained for the remainder of the pointing trajectory such that the difference between stay 
and jump trials was noted for 84% and 74% of the movement for T3T1 and T3T5 trials 
respectively. Similar results were observed for large displacements for movements initially 
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directed at T5. T5T3 diverged at 25% and T5T7 diverged at 14% into the total y-movement 
with differences in trajectory being significant between stay and jump trials for 75% and 86% 
of the pointing movement respectively. The pair-wise functional comparisons of small target 
displacements revealed a smooth divergence in reach trajectories at 31%, 30%, 28% and 42% 
of the total y-movement for T3T2, T3T4, T5T4 and T5T6 conditions respectively. All jump 
trajectories significantly differed in the x-dimension from their relative stay trial from the 
identified point of divergence onwards (i.e. until the endpoint of movement). That is, the 
small target displacements stay and jump trajectories were significantly different for 69%, 
70%, 72%, and 58% of the movement for T3T2, T3T4, T3T5 and T5T6 conditions 
respectively. A significant interaction between condition and group was observed only for 
T3T4 trials between frames 20 (at 6% of total y-movement) and 46 (at 15% of total y-
movement) for a duration of 9% of the trajectory. Group did not interact with condition in 
any of the other functional pair-wise comparisons, suggesting that disease status did not 
significantly affect the ability to diverge trajectories online. Similarly, Medication Status 
significantly interacted with Condition for only the T5T4 pairwise-comparisons between 
frames 9 (at 3% of total y-movement) and 26 (at 9% of total y-movement), for a duration of 
6% of the trajectory. All other functional comparisons did not reveal any significant 
interactions between Group or Medication Status. This indicates that PD diagnosis and 
medication status did not significantly influence the point at which movements began to 
diverge when target location moved relative to when the target position remained invariant. 
Of importance, there was not a significant 3-way interaction between Group, Medication 
Status, and Condition (i.e., stay vs. jump) for any of the functional pair-wise comparisons.   
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Chapter 4: Discussion 
4.1 General Summary of Results 
In the present study, we investigated the extent to which in-flight reach corrections 
could be performed automatically in a sample of PD patients, both with and without 
conscious awareness of the need for reach adjustments. The validity of our methodological 
design relied on the premise that saccade RT, and thus the target jump timing, did not differ 
between groups or across medication status. We directly confirmed that orienting saccades 
were not delayed in PD, and further that medication status did not alter saccade latency. As a 
control, we directly confirmed that the latency of the target jump was in fact equal between 
groups and across medication statuses. An alternative forced-choice task was used to 
empirically confirm that altering the size of intra-saccadic target jumps was an effective 
method for manipulating conscious perceptual awareness. More specifically, small intra-
saccadic target jumps were presented below the threshold for conscious perceptual awareness 
of change, whereas large intra-saccadic target jumps reached threshold for conscious 
perceptual awareness. Dopaminergic medication did not significantly affect either group’s 
perceptual threshold. Taken together, we were able to manipulate conscious awareness of 
target jumps independent of motor demands, rendering all conditions more equivalent in 
terms of difficulty for PD patients and healthy controls.   
To assess baseline differences in hand kinematics, we first assessed performance 
during stationary target trials. An overall increase in hand RT and decrease in peak velocity 
was observed for PD patients relative to controls, indicating that the patient group 
experienced disease-associated bradykinesia. In accordance with our original critique, our 
results support the notion that triggering a target displacement at hand movement onset, as 
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per previously applied methodology, would increase the initial preparatory phase for the PD 
group relative to the healthy controls. Critically, no other movement characteristics differed 
between groups, allowing for more straightforward assessment of the online motor corrective 
system in perturbed target trials.  
MD difference scores were equivalent between our control and patient groups for all 
sized target jumps and across all medication statuses. In our PD group, target displacements 
did not affect the overall MD for both consciously perceived and subliminal online 
corrections. This is analogous to the pattern observed in healthy young controls. These results 
stress the similarity in performance of consciously perceived versus subliminal online motor 
corrections in PD patients. This pattern implies that the degree of consciousness and control 
over the corrective system is irrelevant for the engagement of the automatic pilot in PD 
participants.  
For our healthy, elderly controls, we did find that in two out of four conditions, MD 
difference scores were greater than zero (i.e., jump target trajectories took significantly 
longer than stationary target trials). Despite this increase in MD, smooth, online corrections 
still occurred early into the movement execution for healthy age-matched controls. Again, 
these corrections were statistically equal to those of PD patients and were unaffected by 
dopaminergic therapy. 
The most significant findings of this study relate to the intact automatic processing of 
the corrective system in PD. After controlling for potential confounds, we showed that 
conscious awareness did not affect the online reach corrections of PD patients. Specifically, 
we did not find any differences in terms of where trajectories diverged for jump trials relative 
to stationary trials between PD and control groups for either small, undetected, or large, and 
hence consciously-perceived, target jumps. Moreover, our kinematic analysis included eight 
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replications in each of the On and the Off dopamine medication sessions due to numerous 
different endpoints and initial starting positions. For seven replications, the point of 
divergence was not affected by dopaminergic medication and for seven replications, it was 
not affected by group. These results were irrespective of jump size. There was one instance in 
which Group and one instance in which Dopaminergic Status affected jump trajectory for 
brief and unsustained periods during the movement trajectories. These differences were 
observed for PD patients compared to controls during 6-15% of the trajectory period for 
T3T4 and for dopaminergic therapy during the 3-9% of the trajectory for T3T5. These 
differences in trajectories occurred before the point of sustained divergence between Jump 
and Stay trials and their significance is unclear. 
4.2 Online Motor Control in Healthy Ageing and in Parkinson’s 
Disease 
As mentioned in the General Summary of Results, target displacements were shown 
to elicit increased MDs for healthy aged-matched controls in two out of four of our jump 
conditions. Several previous studies have provided evidence for age-induced deficits in 
online motor control, with older adults taking markedly longer to initiate corrections 
(Plotnick et al., 1996; Rossit & Harvey, 2008; Sarlegna, 2006). Though delayed corrective 
mechanisms in older adults might relate closely to general impairments in central planning 
that naturally accompany ageing, Rossit and Harvery (2008) found that overall smoothness 
and accuracy for older healthy adults for amended trajectories remained comparable to that of 
younger adults, as we found here. In their study, Rossit and Harvery (2008) reported MD 
difference scores of approximately 50 ms longer for elderly participants relative to younger 
participants, leading them to suggest that the corrections of older adults remained too rapid 
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for a new motor command to have been completely reprogrammed. Moreover, their data 
showed that slowness in RTs was not restricted to perturbed double-step trials, but rather 
older adults also took longer to initiate movements in unperturbed trials. Consequently, it was 
argued that online corrections were still being performed with a high degree of automaticity; 
however, general age-related declines in processing speed may have enhanced latencies in 
their corrective movements. It is unclear whether this trend will persist in our data when an 
increased number of participants are added.   
Interestingly, in contrast, increases in MD were not observed for our PD group in any 
of the jump conditions. Nonetheless, our data for PD participants appears to be trending in a 
similar direction as the control results. One possibility for this anomaly between PD patients 
and controls could relate to the greater within-group variability for our PD data that prevents 
such trends from reaching significance. Provided that there is high heterogeneity in the 
phenotypes of PD patients, it might be necessary to increase our power to observe significant 
differences in MD for jump target trials relative to stay target trials (Foltynie et al., 2002; 
Lewis et al., 2005). Though less likely, it might be possible that patients with PD are 
refractory to age-related impairments in online motor control, owing to dorsal striatal 
dysfunction enhancing automatic behavioural responses and online guidance (Benke et al., 
2003; Cameron et al., 2010; Cools et al., 2010; Klockgether et al., 1994; Reed, 1998). In 
theory, dorsal striatal impairments might lead to motor performance being guided by greater 
automaticity, yielding enhanced performance by PD patients on tasks such as the automatic 
double-step paradigm. Alternatively, Reed (1998) posited that patients with PD might 
experience increased reliance on online motor control as a compensatory mechanism for the 
initial noise in their motor system during the pre-programming motor phase. Noise and 
variability in the PD motor system might be attributable to dysregulation of striatal circuits, 
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and thus inconsistent premotor cortex activation. Though speculative, our current data seems 
to support the contention that striatal dysfunction might elicit an advanced online monitoring 
and corrective system in PD to overcome these disruptions. The addition of more participants 
will help clarify these hypotheses.  
The greatest insight into the online corrective system comes from our analyses of the 
reach divergence points. This functional analysis of online corrections indicated that neither 
Group nor Medication Status interacted with Condition (i.e. divergence point) across any of 
the frames for the vast majority of reach comparisons. The consistency in divergence scores 
suggests that PD patients and healthy controls were able to elicit corrections at approximately 
the same point in their reach trajectories and that these smooth changes in trajectory were 
maintained once they occurred, irrespective of Group or Medication Status. However, Group 
did interact with Condition for T3T4 comparisons between 6% and 15% of the overall 
movements. We do not believe that this interaction is reflective of significant differences in 
online corrections between groups. First, this interaction occurred at a non-critical point in 
the overall reach trajectory. More importantly, there were no significant interactions at 
relevantly defined points in the trajectory, such as at the point of divergence, which occurred 
at 42% of the overall reach, or at reach endpoint. Similarly, Dopaminergic Status briefly 
interacted with Condition at the 3-9% time points in overall movement trajectory for 
displacements T5T4. Again, this point of interaction occurred well before the point of 
divergence and reach endpoint. Increased path variability between-subjects may have led to 
these two potentially spurious interactions earlier on in the reach. Further subjects should be 
tested to investigate the significance of this finding.  
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4.3 Conscious Awareness of Online Corrections  
The main objective of this study was to elucidate how conscious perceptual 
awareness of target position change affects PD patients’ ability to elicit automatic, online 
reach corrections. Our results indicate that conscious awareness did not alter the degree to 
which participants with PD could perform corrections automatically. Corrections in fact 
started earlier for both PD and controls for the consciously-perceived target perturbations 
relative to the subliminal perturbations. This was demonstrated by earlier correction times. 
We attribute this difference to the size of the target displacement that had to be 
accommodated with a smooth online change. We interpret that divergence appeared earlier 
for larger (consciously-perceived) jumps because the change in direction is greater relative to 
the small (subliminal) jumps. The corrective system will aim to make the change smooth and 
gradual, even after the intention to change end point has been registered. It is therefore likely 
that both sized jumps start to diverge at the same time, but this smaller change in trajectory 
takes slightly more time to diverge significantly from the original trajectory, given more 
similar endpoints for small relative to large jumps.  
 The results of the present study directly oppose those established by Desmurget et al. 
(2004), which found PD-related deficits in consciously-perceived target changes, whereas 
subliminal changes in target locations were performed normally by PD patients. We have 
identified two potential explanations for our conflicting results. First, Desmurget et al. (2004) 
applied a between-subject design, using different PD participants in their conscious double-
step task than in their subliminal double-step task, making their results less comparable 
across these different experiments. Further, they included patients in both of their 
experiments, one in which target changes were consciously perceived (n=5) and one in which 
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they were not (n=7), who had atypical ages of PD onset (i.e., < age 40) and with highly 
variable disease durations. These participant characteristics, as well as the small number of 
patients, make their results less generalizable and reliable. PD is a highly heterogeneous 
neurological disorder, often presenting differently among patients. For this reason, we used a 
within-subject design to help limit any additional sources of variability within our data. 
Furthermore, we applied strict inclusion and exclusion criteria, restricting our sample of PD 
participants to ensure all patients had a specific diagnosis of idiopathic PD and presented 
with typical PD features. 
 More significantly, as we discussed previously, Desmurget and colleagues (2004) 
failed to dissociate the conscious perception of the target jump from the temporal aspects of 
the target jump. Critically, in their study, consciously perceivable target displacements were 
yoked to the initiation of a participant’s pointing movement, whereas subliminal target 
displacements were yoked to initial pro-saccades. PD-related limb bradykinesia would have 
led to target perturbation at movement onset, increasing the time PD patients had to plan and 
prepare their action toward the initial target position. When we equalized the preparatory 
phase between both groups, we did not find impairments in automatic action control, even 
with consciously-perceived target displacement in our PD sample. Therefore, our data 
suggest that the length of time one has to plan and prepare the initial action might influence 
the overall motor fluidity and flexibility. A similar conclusion can be derived from previous 
work that has collectively established temporal limitations on online corrections. For 
example, Liu and Todorov (2007) demonstrated that young healthy adults were unable to 
fully amend their trajectories in response to late-occurring target perturbations (i.e. 300 ms 
following movement onset). Likewise, delayed corrections have also been observed when 
targets are displaced at the time of peak movement velocity (Komilis et al., 1993). As a 
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movement plan significantly progresses, the visuomotor system might become less efficient 
at correcting potential errors (Liu & Todorov, 2007; Sarlegna & Mutha, 2014). One theory is 
that the information surrounding the precise target location might become less relevant in the 
latter parts of the movement as the motor control system is more heavily focused on endpoint 
stability (Liu & Todorov, 2007). Undoubtedly, the visuomotor system must take into 
consideration the costs (i.e. time and stability) and benefits (i.e. precision) before facilitating 
an online correction. Taken together, we believe that the previously reported PD-related 
deficits in conscious online motor control might have arisen as a consequence of additional 
temporal constraints disproportionately affecting the PD group relative to the controls.  
4.4 Role of Striatum/Basal Ganglia in Movement Generation 
and Online Motor Control 
Interestingly, we did not find a clear and significant effect of exogenous dopamine on 
our measured motor variables. However, PD patients had significantly slower hand 
movement RTs and peak velocities overall. We confirmed that PD participants properly 
adhered to the medication schedule by performing clinical exams and estimating motor 
function with the standardized UPDRS during both sessions. UPDRS scores were 
significantly higher when participants were scheduled to be off of their dopaminergic 
medication compared to when they were scheduled to be on their dopaminergic medication. 
This also helped verify that testing did not occur during a “wearing-off” period for the On 
testing sessions, when patients were taking their usual dopaminergic therapy.  
It is worth noting that impairments in PD and correspondingly the magnitude of 
improvements related to exogenous dopamine seem greater with increasing task complexity 
(Benecke et al., 1987; Hanna-Pladdy & Heilman, 2010). That is, PD patients are expected to 
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experience the greatest improvement in functioning with medication during more demanding 
motor processes, such as when an action has to be initiated and a competing response is 
inhibited or when complex motor sequences, with multiple, chained action plans are 
performed (Hood et al., 2007; Shook et al., 2005). It is possible that the relatively simplistic 
reaching movement that is elicited by a target is less impaired in PD and hence less sensitive 
to On-Off differences. This interpretation is supported by reports that performance of PD 
patients in simple behavioral paradigms, such as RT tasks, does not improve under 
dopaminergic medication (Jahanshahi et al., 1992; Jordan et al., 1992; Müller et al., 2001).   
Given that online motor corrections involve the smooth modulation of ongoing 
responses and do not require complex motor switching, it is not completely unexpected that 
PD participants performed this automatic function normally compared to age-matched 
controls and that dopaminergic therapy did not alter performance. Further, the fact that we 
did not find any between group differences in online corrections questions the role of the 
dopaminergic system-striatum/basal ganglia in enactment of online motor corrections. In 
theory, if dopaminergic pathways in the basal ganglia truly mediate the online corrective 
response, then diminished dopamine supplies associated with PD would hinder functioning in 
this domain. Similarly, replenishing these dopamine levels should improve performance. 
In the literature there are conflicting reports as to the exact role, if any, of the basal 
ganglia in the online control of action. Reduced capabilities in performing smooth and 
efficient corrective movements online have been reported in only few experiments 
investigating patients with HD (Smith et al., 1999) and PD (Desmurget et al., 2004; Tunik et 
al., 2004). Although some groups have supported these clinical findings by showing 
increased activity in the Gpi and STN of healthy controls during the error correction (Grafton 
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& Tunik, 2011; Tunik et al., 2009), other groups have not (Desmurget et al., 2001; 
Diedrichsen et al., 2005; Jueptner & Weiller, 1998).  
Initially, our data appears to be at odds with previous clinical reports.  However, we 
suggest that evidence from HD patients must be interpreted cautiously. Given that atrophy 
beyond the basal ganglia circuits is common even in the preliminary stages of HD, it is 
difficult to attribute impairments in online movement guidance strictly to this region 
(Ciarmiello et al., 2006; Hedreen et al., 1991; Rosas et al., 2008; Walker, 2007).  Moreover, 
in the few other studies reporting a role of the basal ganglia, corrective errors were evoked 
through viscous mechanical perturbations of the limb or body position, which elicited the 
additional need for dynamic control of force (Grafton & Tunik, 2011; Tunik et al., 2004; 
Tunik et al., 2009). We postulate that our double-step design measures a much more 
simplistic and direct automatic form of online visuomotor corrections. Finally, Desmurget et 
al. (2004) only reported deficits in the online corrective system when target displacements 
were evoked at hand movement onset, which posed the possibility for a confounding 
influence of disease-related bradykinesia on PD performance. In this way, the cause of our 
apparently discrepant results is clarified.  
In contrast, when online feedback and motor control is investigated in the absence of 
unpredictable effector perturbations and confounding disease pathology, a wide breath of 
studies support our proposal that the basal ganglia are uninvolved in rapidly controlling 
ongoing actions. First, using PET, Desmurget et al. (2001) failed to find changes in striatal 
activity during double-step trials, which evoke automatic online guidance, relative to single-
step trials, which do not. Instead, metabolic changes in activity were restricted to the 
contralateral PPC, contralateral motor cortex and ipsilateral anterior cerebellum during the 
generation of corrective movements (Desmurget et al., 2001). Likewise, event-related fMRI 
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designs have investigated the neural substrates involved in the planning and online control of 
motor sequences and have found increased striatal activity exclusive to when the action is 
being preprogramed or internally generated. Notably, no such increases in striatal activity 
were reported during the online execution of motor sequences or during online sensory 
feedback processing (Boecker et al., 2008; Elsinger et al., 2006; Ogawa et al., 2006). 
Congruent with this, overwhelming evidence suggests that PD patients are in fact able to 
continuously use sensory feedback during reaching or tracking movements (Bloxham et al., 
1984; Day et al., 1984; Flowers et al., 1976; Ghilardi et al., 2000).	  Pertinent to our findings, 
Johnson et al. (1994) also reported that exogenous dopamine medication had no effect on the 
ability for PD patients to control their movements in an online visual tracking task. As first 
alluded to by Desmurget et al. (2004), if the dorsal striatum is truly responsible for the online 
processing of actions, then patients with PD should present with deficits in their ability to use 
visual feedback in these tasks. Furthermore, increasing dopamine supplies to mediate dorsal 
striatal function should improve performance in this domain. Our data, along with others, 
contend that this is not the case. PD patients, regardless of dopaminergic medication status, 
were consistently capable of using online feedback to update their internal representations of 
goal positions and amend their actions appropriately in-flight. Taken together, the paucity of 
reports of impaired online control in patients with basal ganglia abnormalities, in contrast 
with the extensive documentation of other motor and cognitive deficits in PD and patients 
with BG lesions (Jankovic, 2008; Kudlicka et al., 2011; Moustafa et al., 2016; Park & Stacy, 
2009), could further be in support of our findings. 
Several alternative roles have been suggested for the dorsal striatum in subserving 
both motor and cognitive control. Under conditions in which dorsal striatal dopamine is 
deplete, as prevalent in PD, deficits in decision making, specifically related to action 
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selection and initiation in ambiguous contexts (Cools et al., 2006; Ell et al., 2006; Thoma et 
al., 2008; Troyer et al., 2004) and attentional set shifting (Hayes et al., 1998; Hood et al., 
2007; Shook et al., 2005) are observed. Additionally, the dorsal striatum has been implicated 
in reducing the distractibility of highly salient, yet task irrelevant stimuli (Benke et al., 2003; 
Cools et al., 2006; Cools et al., 2010). For example, patients with PD are more likely to 
attend to the more salient stimuli	  among distractors and select the more automatic or well-
practiced response. Congruent with these results, the dorsal striatum is well-positioned 
anatomically to integrate information from multiple modalities and broadly allocate attention 
in space and time (MacDonald & Monchi, 2011). Consequently, when this region is impaired 
attention becomes more narrowed and deliberate responses are harder to initiate over 
responses that are over-learned or automatic. We suggest that because online reach 
adjustments are highly automatized and can occur without volitional control, such 
behavioural responses should not rely on intact dorsal striatal functioning.  
4.5 Automaticity in Parkinson’s Disease  
Rapid online reach corrections are an automatic default response that can occur in 
healthy participants with and without conscious perceptual awareness or control. These 
corrections provide a naturalistic and well-understood proxy for directly investigating 
automaticity in an experimental setting. Our results clearly demonstrated that PD participants 
were neither impaired during consciously perceived corrections nor during subliminally 
presented automatic corrections, suggesting preservation of motor automaticity in PD.  
Our results correspond well with those from oculomotor studies that suggest that PD 
patients perform with the same, if not greater, automaticity than healthy controls (Chan et al., 
2005; Fielding et al., 2005; Praamstra et al., 2001). In addition, studies examining cognitive 
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control have emphasized similar patterns of highly automated responses in PD participants 
during assessments such as the Stroop task (Brown & Marsden, 1988; Djamshidian et al., 
2011; Dujardin et al., 1999).  As discussed earlier, deficits in suppressing automatic response 
mechanisms have been posited throughout the PD literature (Henik et al., 1993; Obeso et al., 
2011; Praamstra et al., 2001). If these trends hold true, we would speculate that PD would 
also selectively impair higher-level volitional processes, such as inhibiting or 
countermanding automatic online reach amendments. Such an outcome would further suggest 
a relatively dominant level of automaticity in PD that mirrors that of healthy controls. 
Ultimately, the disruption in inhibitory outputs from the basal ganglia would lead to 
disinhibition of certain reflexive or impulsive orienting systems in PD. In theory this should 
translate into a double dissociation between impaired volitional control and spared 
automaticity in PD.  
4.6 Limitations and Future Directions 
Although our study is able to answer fundamental questions regarding the automatic 
pilot in PD, we acknowledge that it contains inherent limitations. First, we must recognize 
that our conclusion of intact online automatic action control in PD and our interpretations 
that the basal ganglia are not involved in mediating this process rely on a null result. That is, 
PD patients and controls, both on and off medication, performed statistically equivalent on all 
of our critical measures. In response to this, we suggest that our results are not simply 
attributable to a lack of statistical power, nor could features of our paradigm render it 
insensitive to detect true differences. First, we showed that our experimental paradigm was in 
fact capable of reliably detecting divergences in trajectories between stay and jump trials. 
Divergence in reach trajectories became significantly apparent early-on in the action, 
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suggesting that our functional data techniques were sensitive to slight changes in positioning. 
Secondly, we used more than double the number of PD patients in our study than were used 
in Desmurget et al.’s (2004) original design. Given that despite their small sample size, 
Desmurget et al. (2004) still reported significant differences between healthy controls and PD 
patients, we have confidence that our experiment was in fact powered significantly.  Last and 
most compelling, we had a total of 8 different replications in both the On medication session 
and the Off medication session to find differences between PD and healthy controls if they 
were indeed present. That is, we looked at 8 separate trajectories contrasting Condition (Jump 
vs. Stay), Group (PD vs. Control) and Medication Status (On vs. Off).  Importantly, in all 
cases, there were no significant differences between PD patients and healthy controls, nor 
were there significant effects across medication status. Nevertheless, the Condition variable 
was significant for all comparisons. Further, the divergence started at similar time points for 
these trials, with the small jumps having slightly later points of divergence and the large 
jumps having slightly earlier points of divergence, with explanation for this difference 
provided. Taken together, our high number of replications, larger sample size and sensitive 
analyses provides us with confidence that our findings are not simply attributable to a Type 2 
error.   
Additionally, caution must be applied when interpreting our lack of dopaminergic 
effects on online motor control. Given the absence of drug effects on all of our motor 
variables our interpretation is limited. Whether our null finding surrounding dopaminergic 
medication is due to the dopaminergic system itself not being involved in the automatic pilot 
or because our task was insensitive to capture any On-Off medication differences remains 
inconclusive. Increasing our power would improve the reliability and generalizability of 
these results.  
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 Further, our investigation of automaticity in PD was restricted exclusively to online 
corrections induced through the double-step paradigm. The double-step paradigm elicits 
automatic corrections by inducing an unexpected spatial error between hand and target 
position. In contrast, other studies have worked under the loose definition that an action is 
automatic so long as it can be performed in the absence of cognitive resources (Doyon et al., 
1997; Faglioni, et al., 1995; Wylie et al., 2009). In this manner, automaticity can be 
investigated by ‘over-training’ participants on a complex motor sequence and having the 
habitually-learned sequence be performed simultaneously with a competing cognitive load. 
Whether these tasks would encompass the same behaviors as automatic online corrections is 
uncertain. To our knowledge, no study to date has investigated the similarities and/or 
differences in the neural correlates and psychomotor demands between these two measures. 
Presumably, it is critical to distinguish between different forms of automaticity before being 
able to fully generalize our results.   
 Finally, we are unable to directly disconfirm the role of the basal ganglia in the 
automatic corrective system, as this study was performed only at the behavioral level. It 
would be necessary to integrate functional imaging into our design to investigate the exact 
neural substrates involved in online corrections in individuals with PD.  
4.7 Conclusions 
PD is primarily recognized by its cardinal motor symptoms, including tremor, rigidity 
and bradykinesia. Our results emphasize the importance of isolating the motor symptoms of 
PD when investigating online motor control. This thesis argues that the previous work 
examining online motor control was confounded by PD-related bradykinesia and 
consequently led to the misinterpretation that patients with PD are also impaired in 
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consciously mediated automatic online corrections. Our results suggest that PD neither 
affects consciously mediated nor subliminal automaticity, as measured by the double-step 
paradigm. Equalizing the preparatory phase and thus the task demands between groups 
allowed PD patients to perform online corrections similar to those without basal ganglia 
dysfunction. Additionally, we did not find any evidence for a role of the dopaminergic 
system in the automatic pilot. We suggest that regions beyond the dopamine dependent 
striatal loops are critical for mediating online motor guidance.  
The outcomes from this study have several far-reaching implications. Our results 
discredit the assumption that there is a dichotomy between conscious and subconscious 
automatic online processing in PD. To this extent, our findings contribute to an improved 
understanding of automaticity and online motor control in PD and help clarify previous 
inconsistencies in the literature. Moreover, our results translate into a better appreciation for 
the exact motor symptoms of PD and advise for further clarification into the role, if any, of 
the basal ganglia in the online control of action. 
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Appendices  
Appendix A:  Participant Inclusion/Exclusion Criteria  
Healthy Controls Patients with PD 
No diagnosis of a movement disorder  Diagnosis of idiopathic PD from a licensed 
clinical neurologist 
No history of: 
1. Neurological illness 
2. Psychiatric illness 
3. Neuro-trauma  
4. Psychosis or hallucinations 
No history of the following unrelated to PD: 
1. Neurological illness 
2. Psychiatric illness 
3. Neuro-trauma 
4. Psychosis or hallucinations 
Normal or corrected-to-normal vision Normal or corrected-to-normal vision 
No previous participation in the study No previous participation in the study 
No history of substance abuse (ETOH, 
prescription medication, illicit drugs) 
No history of substance abuse (ETOH, 
prescription medication, illicit drugs)  
Not currently taking cognitive-enhancing 
medications including: 
1. Donepezil 
2. Galantamine 
3. Rivastigimine 
4. Memantine 
5. Methylphenidate 
Not currently taking cognitive-enhancing 
medications including: 
1. Donepezil 
2. Galantamine 
3. Rivastigimine 
4. Memantine 
5. Methylphenidate 
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No clinical diagnosis of dementia or mild 
cognitive impairment 
Responsive to dopaminergic medication 
 Currently prescribed and taking dopaminergic 
medication 
 Disease duration < 15 years 
 No suspicion of familial form of PD (greater 
than 2 first degree relatives with PD diagnosis) 
 No clinical diagnosis of dementia or mild 
cognitive impairment 
 Must not have unstable or rapidly progressing 
parkinsonism  
 No history of treatment of deep brain 
stimulation or neurological surgery 
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Appendix B: Consent Form  
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Appendix C: Starkstein Apathy Scale 
Starkstein	  Apathy	  Scale	  
Instructions:	  For	  each	  question,	  indicate	  as	  “Not	  at	  all”,	  “Slightly”,	  “Some”,	  or	  “A	  lot”	  with	  
an	  ‘X’	  while	  leaving	  the	  other	  spaces	  blank.	   
Questions	   Not	  at	  all	   Slightly	   Some	   A	  lot	  
1.	  Are	  you	  interested	  in	  learning	  
new	  things?	   	   	   	   	  
2.	  Does	  anything	  interest	  you?	   	   	   	   	  
3.	  Are	  you	  concerned	  about	  your	  
condition?	   	   	   	   	  
4.	  Do	  you	  put	  much	  effort	  into	  
things?	   	   	   	   	  
5.	  Are	  you	  always	  looking	  for	  
something	  to	  do?	   	   	   	   	  
6.	  Do	  you	  have	  plans	  and	  goals	  for	  
the	  future?	   	   	   	   	  
7.	  Do	  you	  have	  motivation?	  
	   	   	   	   	  
8.	  Do	  you	  have	  the	  energy	  for	  daily	  
activities?	   	   	   	   	  
9.	  Does	  someone	  have	  to	  tell	  you	  
what	  to	  do	  each	  day?	   	   	   	   	  
10.	  Are	  you	  indifferent	  to	  things?	   	   	   	   	  
11.	  Are	  you	  unconcerned	  with	  many	  
things?	   	   	   	   	  
12.	  Do	  you	  need	  a	  push	  to	  get	  
started	  on	  things?	   	   	   	   	  
13.	  Are	  you	  neither	  happy	  nor	  sad,	  
just	  in	  between?	   	   	   	   	  
14.	  Would	  you	  consider	  yourself	  
apathetic?	   	   	   	   	  
 
 
 
For	  administrator’s	  use	  only	   	   Date	  (dd/mm/yy):	  
	   	   	   	   	   Subject	  #:	   	   	   Session	  #:	  
Score:	   	   	   	   	   Medication:	   	   	   Time:	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Appendix D: Montreal Cognitive Assessment  
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Appendix E: Montreal Cognitive Assessment Evaluation Scale 
MoCA Version August 18, 2010 © Z. Nasreddine MD www.mocatest.org 1 
 
Montreal Cognitive Assessment (MoCA) 
 
Administration and Scoring Instructions 
The Montreal Cognitive Assessment (MoCA) was designed as a rapid screening instrument for mild 
cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive 
functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and 
orientation. Time to administer the MoCA is approximately 10 minutes. The total possible score is 30 
points; a score of 26 or above is considered normal. 
 
1. Alternating Trail Making: 
Administration: The examiner instructs the subject: "Please draw a line, going from a number 
to a letter in ascending order. Begin here [point to (1)] and draw a line from 1 then to A 
then to 2 and so on. End here [point to (E)]." 
 
Scoring: Allocate one point if the subject successfully draws the following pattern: 
1 −A- 2- B- 3- C- 4- D- 5- E, without drawing any lines that cross. Any error that is not 
immediately self-corrected earns a score of 0. 
 
2. Visuoconstructional Skills (Cube): 
Administration: The examiner gives the following instructions, pointing to the cube: “Copy this 
drawing as accurately as you can, in the space below”. 
 
Scoring: One point is allocated for a correctly executed drawing. 
• Drawing must be three-dimensional 
• All lines are drawn 
• No line is added 
• Lines are relatively parallel and their length is similar (rectangular prisms are accepted) 
A point is not assigned if any of the above-criteria are not met. 
 
3. Visuoconstructional Skills (Clock): 
Administration: Indicate the right third of the space and give the following instructions: “Draw 
a clock. Put in all the numbers and set the time to 10 past 11”. 
 
Scoring: One point is allocated for each of the following three criteria: 
• Contour (1 pt.): the clock face must be a circle with only minor distortion acceptable (e.g., 
slight imperfection on closing the circle); 
• Numbers (1 pt.): all clock numbers must be present with no additional numbers; numbers 
must be in the correct order and placed in the approximate quadrants on the clock face; Roman 
numerals are acceptable; numbers can be placed outside the circle contour; 
• Hands (1 pt.): there must be two hands jointly indicating the correct time; the hour hand must 
be clearly shorter than the minute hand; hands must be centred within the clock face with their 
junction close to the clock centre. 
A point is not assigned for a given element if any of the above-criteria are not met. 
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4. Naming: 
Administration: Beginning on the left, point to each figure and say: “Tell me the name of this 
animal”. 
 
Scoring: One point each is given for the following responses: (1) lion (2) rhinoceros or rhino 
(3) camel or dromedary. 
 
5. Memory: 
Administration: The examiner reads a list of 5 words at a rate of one per second, giving the following 
instructions: “This is a memory test. I am going to read a list of words that you will have to 
remember now and later on. Listen carefully. When I am through, tell me as many words as 
you can remember. It doesn’t matter in what order you say them”. 
 
Mark a check in the allocated space for each word the subject produces on this first trial. When 
the subject indicates that (s)he has finished (has recalled all words), or can recall no more 
words, read the list a second time with the following instructions: “I am going to read the same 
list for a second time.Try to remember and tell me as many words as you can, including words you 
said the first time.”  
 
Put a check in the allocated space for each word the subject recalls after the second trial. 
At the end of the second trial, inform the subject that (s)he will be asked to recall these words again 
by saying, “I will ask you to recall those words again at the end of the test.” 
 
Scoring: No points are given for Trials One and Two. 
 
6. Attention: Forward Digit Span:  
Administration: Give the following instruction: “I am going to say some numbers and when I am 
through, repeat them to me exactly as I said them”. Read the five number sequence at a rate of one 
digit per second. 
Backward Digit Span:  
Administration: Give the following instruction: “Now I am going to say some more numbers, but 
when I am through you must repeat them to me in the backwards order.”  Read the three number 
sequence at a rate of one digit per second. 
 
Scoring: Allocate one point for each sequence correctly repeated, (N.B.: the correct response for the 
backwards trial is 2-4-7). 
 
Vigilance:  
Administration: The examiner reads the list of letters at a rate of one per second, after giving the 
following instruction: “I am going to read a sequence of letters. Every time I 
say the letter A, tap your hand once. If I say a different letter, do not tap your hand”. 
 
Scoring: Give one point if there is zero to one errors (an error is a tap on a wrong letter or a 
failure to tap on letter A). 
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Administration: The examiner gives the following instruction: “Now, I will ask you to count by 
subtracting seven from 100, and then, keep subtracting seven from your answer until I tell you to 
stop.” Give this instruction twice if necessary. 
 
Scoring: This item is scored out of 3 points. Give no (0) points for no correct subtractions, 1 point for 
one correction subtraction, 2 points for two-to-three correct subtractions, and 3 points if the 
participant successfully makes four or five correct subtractions. Count each correct subtraction of 7 
beginning at 100. Each subtraction is evaluated independently; that is, if the participant responds with 
an incorrect number but continues to correctly subtract 7 from it, give a point for each correct 
subtraction. For example, a participant may respond “92 – 85 – 78 – 71 
– 64” where the “92” is incorrect, but all subsequent numbers are subtracted correctly. This is one 
error and the item would be given a score of 3. 
 
7. Sentence Repetition: 
Administration: The examiner gives the following instructions: “I am going to read you a sentence. 
Repeat it after me, exactly as I say it [pause]: I only know that John is the one to help today.”  
 
 Following the response, say: “Now I am going to read you another sentence.Repeat it after me, 
exactly as I say it [pause]: The cat always hid under the couch when dogs were in the room.” 
 
Scoring: Allocate 1 point for each sentence correctly repeated. Repetition must be exact. Be alert for 
errors that are omissions (e.g., omitting "only", "always") and substitutions/additions 
(e.g., "John is the one who helped today;" substituting "hides" for "hid", altering plurals, etc.). 
 
8. Verbal fluency: 
Administration: The examiner gives the following instruction: “Tell me as many words as you can 
think of that begin with a certain letter of the alphabet that I will tell you in a moment. You can say 
any kind of word you want, except for proper nouns (like Bob or Boston), numbers, or words that 
begin with the same sound but have a different suffix, for example, love, lover, loving. I will tell you to 
stop after one minute. Are you ready? [Pause] Now, tell me as many words as you can think of that 
begin with the letter F. [time for 60 sec]. Stop.” 
 
Scoring: Allocate one point if the subject generates 11 words or more in 60 sec. Record the subject’s 
response in the bottom or side margins. 
 
9. Abstraction: 
Administration: The examiner asks the subject to explain what each pair of words has in common, 
starting with the example: “Tell me how an orange and a banana are alike”. If the subject answers in 
a concrete manner, then say only one additional time: “Tell me another way in which those items are 
alike”. If the subject does not give the appropriate response (fruit), say, “Yes, and they are also both 
fruit.” Do not give any additional instructions or clarification. After the practice trial, say: “Now, tell 
me how a train and a bicycle are alike”. Following the response, administer the second trial, saying: 
“Now tell me how a ruler and a watch are alike”. 
Do not give any additional instructions or prompts. 
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The following responses are not acceptable: Train-bicycle = they have wheels; Ruler-watch 
= they have numbers. 
 
10. Delayed recall: 
Administration: The examiner gives the following instruction: “I read some words to you 
earlier, which I asked you to remember. Tell me as many of those words as you can 
remember.” Make a check mark  for each of the words correctly recalled spontaneously 
without any cues, in the allocated space. 
 
Scoring: Allocate 1 point for each word recalled freely without any cues. 
Optional: Following the delayed free recall trial, prompt the subject with the semantic category cue 
provided below for any word not recalled. Make a check mark ( √ ) in the allocated space if the 
subject remembered the word with the help of a category or multiple-choice cue. Prompt all non-
recalled words in this manner. If the subject does not recall the word after the category cue, give 
him/her a multiple choice trial, using the following example instruction, “Which of the following 
words do you think it was, NOSE, FACE, or HAND?” 
Use the following category and/or multiple-choice cues for each word, when appropriate: 
FACE: category cue: part of the body multiple choice: nose, face, hand 
VELVET: category cue: type of fabric multiple choice: denim, cotton, velvet 
CHURCH: category cue: type of building multiple choice: church, school, hospital 
DAISY: category cue: type of flower multiple choice: rose, daisy, tulip 
RED: category cue: a colour multiple choice: red, blue, green 
 
Scoring: No points are allocated for words recalled with a cue. A cue is used for clinical 
information purposes only and can give the test interpreter additional information about the type of 
memory disorder. For memory deficits due to retrieval failures, performance can be improved with a 
cue. For memory deficits due to encoding failures, performance does not improve with a cue. 
 
11. Orientation: 
Administration: The examiner gives the following instructions: “Tell me the date today”. If the 
subject does not give a complete answer, then prompt accordingly by saying: “Tell me the 
[year, month, exact date, and day of the week].” Then say: “Now, tell me the name of this place, and 
which city it is in.” 
 
Scoring: Give one point for each item correctly answered. The subject must tell the exact date and the 
exact place (name of hospital, clinic, office). No points are allocated if subject makes an error of one 
day for the day and date. 
 
TOTAL SCORE: Sum all sub-scores listed on the right-hand side. Add one point for an 
individual who has 12 years or fewer of formal education, for a possible maximum of 30 points. 
A final total score of 26 and above is considered normal. 
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Appendix F: Bond & Lader Mood Scale  
	  
Bond	  &	  Lader	  Visual	  Analogue	  Mood	  Scale	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For	  administrator’s	  use	  only	   	   Date	  (dd/mm/yy):	  
	   	   	   	   	   Subject	  #:	   	   	   Session	  #:	  
Score:	   	   	   	   	   Medication:	   	   	   Time:	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Appendix G: ANART 
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Appendix  H: Health and Demographic Questionnaire 
Please	  print	  and	  fill	  out	  this	  form	  as	  accurately	  as	  possible	  and	  bring	  it	  with	  you	  to	  your	  first	  
appointment	  session.	  If	  you	  are	  attending	  your	  appointment	  with	  another	  participant,	  please	  ensure	  
you	  both	  have	  your	  own	  personal	  copies	  filled	  out.	  
1.	  Basic	  Demographic	  Information	  
Date	  of	  Birth:	  _____________________________	   	   Age:	  _______	  
Weight:	  _________________	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Height:	  ___________	  
Sex:	  _______	   	   	   	   	   	   	   Handedness:	  _____________	  
First	  language:	  __________________	   Other	  languages:	  ___________________________	  
Level	  of	  Education	  and	  total	  years	  (e.g.	  4	  years	  high	  school,	  4	  years	  university,	  etc.)	  
______________________________________________________________________________	  
Occupation:	  ______________________________	  
2.	  Health-­‐Related	  Information	  
A.	  Smoking	  History	  (please	  circle):	   Never	  Smoker	   	   Ex-­‐Smoker	   Current	  Smoker	  
If	  current	  smoker,	  indicate	  how	  many	  years	  and	  how	  many	  cig/day:	  _______________________	  
If	  ex-­‐smoker,	  indicate	  year	  that	  you	  quit;	  how	  many	  years	  smoking;	  how	  many	  cig/day:	  
______________________________________________________________________________	  
B.	  Alcohol	  History	  
Average	  number	  of	  drinks	  per	  week:	  _____________	  
Has	  there	  ever	  been	  heavy	  alcohol	  consumption?	  (please	  circle)	  Yes	   No	  
If	  yes,	  when,	  for	  how	  long,	  and	  estimate	  your	  weekly	  alcohol	  consumption	  during	  that	  time:	  
______________________________________________________________________________	  
C.	  Other	  Drug	  History	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Have	  you	  ever	  taken	  street	  drugs	  or	  other	  drugs	  that	  were	  not	  prescribed	  by	  a	  physician	  (please	  
circle)?	   	   Yes	   No	  
If	  yes,	  when,	  what	  drugs,	  how	  frequently	  and	  over	  what	  period	  of	  time?	  
______________________________________________________________________________	  
D.	  Eye	  Glasses	  (only	  if	  applicable)	  
What	  is	  the	  prescription	  of	  your	  eye	  glasses?	  ______________	  
Without	  the	  aid	  of	  glasses	  are	  you	  able	  to	  see	  near	  objects	  well	  (please	  circle)?	   Yes	   No	  
Without	  the	  aid	  of	  glasses	  are	  you	  able	  to	  see	  far	  objects	  well	  (please	  circle)?	   Yes	   No	  
E.	  Parkinson’s	  Disease	  (only	  if	  applicable)	  
What	  year	  were	  you	  diagnosed	  with	  Parkinson’s	  disease?	  _________________	  
Which	  side	  of	  the	  body	  is	  more	  affected?	  _________________	  
3.	  Previous	  Medical	  Problems	  
Have	  you	  had	  any	  major	  health	  problems	  or	  do	  you	  have	  any	  chronic,	  ongoing	  medical	  conditions	  
such	  as	  high	  blood	  pressure,	  high	  cholesterol,	  diabetes,	  thyroid	  problems,	  multiple	  sclerosis	  or	  
epilepsy?	  	  Have	  you	  had	  any	  strokes,	  heart	  attacks/	  heart	  surgeries,	  significant	  head	  trauma,	  or	  
cancer?	  	  If	  you've	  had	  cancer,	  what	  kind	  and	  what	  treatments	  did	  you	  receive	  (e.g.	  chemotherapy)?	  
Have	  you	  ever	  had	  more	  than	  one	  seizure?	  Answer	  in	  the	  space	  below.	  
	  
4.	  Family	  Medical	  Problems	  
Is	  there	  anyone	  in	  your	  family	  with	  a	  neurological	  or	  serious	  psychiatric	  illness	  such	  as	  PD,	  
Huntington's,	  epilepsy,	  strokes	  at	  a	  young	  age	  (<	  50	  for	  men	  and	  <	  60	  for	  women)?	  	  Is	  there	  anyone	  
who	  had	  trouble	  walking	  or	  with	  balance,	  needing	  a	  wheelchair	  or	  a	  walker	  at	  a	  young	  age?	  	  Any	  
family	  members	  with	  dementia	  (such	  as	  Alzheimer's),	  schizophrenia,	  bipolar/manic	  depression,	  or	  
severe	  depression	  or	  anxiety	  requiring	  hospitalization	  or	  close	  follow	  up	  by	  a	  psychiatrist?	  Answer	  in	  
the	  space	  below.	  
5.	  Current	  Medication	  
Please	  list	  any	  medications	  you	  are	  currently	  taking,	  what	  they	  are	  treating	  for	  specifically,	  and	  the	  
prescribed	  dosage.	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Appendix I: Levodopa Screening Questionnaire  
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Appendix J: UPDRS Protocol  
UPDRS Protocol 
Ask at the start “which arm/hand do you have most difficulty with?” 
Always start with LESS impaired side 
Only model for a few seconds, then stop 
 
“This is subject (PD/CTRL #), session #, (on/off) medication.” 
1. Film face at rest for a few seconds 
2. Ask patient to speak one-two sentences (for dysarthria) 
• “Today is a very nice day outside” 
• “I am at the University for an experiment” 
3. Evaluate resting tremor  
a. hands relaxed on thighs 
b. with cognitive stressing “Close your eyes and name the months of the year 
backward from December” 
4. Evaluate tone 
a. Bilateral upper extremities 
5. Evaluate postural tremor  
a. hands outstretched 
b. fingertips apposed (forming wings with arms ensuring fingers are not 
touching) 
6. Evaluate action tremor  
a. Finger-to-nose (finger target should be arms-length away and in same 
position) 
7. Evaluate bradykinesia 
a. Finger taps (pinching) “Big and fast” 
b. Hand opening-closing movements “Big and fast” 
c. Pronation-supination movements “Fast as you can” 
d. Toe-tapping  (minimum 3 inches off ground) 
8. Ask patient to rise from the chair without the assistance of his/her arms (arms crossed 
over chest) “Fold your arms across and chest and stand up” 
9. Evaluate gait, ask to walk up and down hallway 2-3 times, with turns 
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10. Pull test “Try to maintain your balance and limit yourself to one step backwards” 
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Appendix K: Ethics Approval 
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